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      Abstract                                                                                                                                                                                                   
Processes of functional plasticity, i.e. long-lasting changes of the strength of 
synaptic connectivity in response to relative short-lasting afferent stimulation, are the 
most likely mechanisms underlying memory storage in the adult brain. The best studied 
models of functional plasticity are long-term potentiation (LTP) and long-term depression 
(LTD).  
It is well known that the 3'-5'-cyclic adenosine monophosphate (cAMP)/protein 
kinase A (PKA) pathway is essential for the prolonged mainentance of LTP as well as 
LTD. Therefore, it was interesting to investigate, how substances with a direct action on 
cellular cAMP-regulation would affect LTP/LTD. Rolipram, a specific type IV-specific 
cAMP phosphodiesterase (PDE) inhibitor, was therefore used in my initial studies to 
investigate its effect on late plastic events during functional CA1 plasticity in rat 
hippocampal slices in vitro. My studies showed that, an early form of LTP which normally 
decays to the baseline within 2-3 h (early-LTP) can be converted to a long-lasting LTP 
(late-LTP) lasting up to 6 h, if rolipram was applied during a weak tetanization. This 
rolipram-reinforced LTP (RLTP) was NMDA-receptor- and protein synthesis-dependent. 
The formation of cAMP during late-LTP in region CA1 requires dopaminergic receptor 
activity (Frey et al., 1989;Frey et al., 1990), thus we have studied whether RLTP was 
influenced by inhibitors of the D1/D5-receptor. Application of the specific D1/D5 
antagonist SCH23390 did not prevent RLTP, suggesting that the phosphodiesterase 
inhibitor acts downstream of the D1/D5-receptors.  Further studies were conducted to 
investigate whether rolipram can interact with processes of synaptic tagging. Synaptic 
tagging provides a conceptual basis for characterizing the mechanisms by which newly 
synthesized proteins that prolong functional changes in synaptic strength may act at 
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specific, recently activated synapses (Frey and Morris, 1997;Frey and Morris, 1998a). 
Inhibition of PDE and subsequent induction of RLTP in one synaptic population S1 was 
able to transform early- into late-LTP in a second, independent synaptic population S2 of 
the same neurons. This supports our hypothesis that cAMP-dependent processes are 
directly involved in the synthesis of plasticity-related proteins (PRPs). 
It has been reported recently that, an atypical PKC isotype PKMzeta (PKMζ) is a 
first LTP specific PRP which is both necessary and sufficient for long-lasting LTP 
maintenance, but not for LTD (Sajikumar et al., 2005b). Thus, our assumption was that 
rolipram may specifically activate the synthesis of PKMζ only during LTP or it is involved 
in a more general regulation of the synthesis of PRPs necessary for both LTP and LTD. 
Thus, if inhibition of PDEs can reinforce an early form of LTP, the next question was 
whether rolipram could reinforce an early form of LTD into a late one.  
In addition to the action of rolipram on LTP, I show here, in the CA1 region of 
hippocampal slices from male adult rats in vitro that rolipram also converts an early form 
of LTD (early-LTD) that normally decays within 2-3 h, to a long-lasting LTD (late-LTD) if 
rolipram was applied during LTD-induction. Rolipram-reinforced LTD (RLTD) was 
NMDA-receptor- and protein synthesis-dependent. Furthermore, it was dependent on 
the synergistic co-activation of dopaminergic D1/D5- and glutamate receptors. The 
question arose whether synaptic tagging occurs during RLTD. I found that early-LTD in a 
synaptic input S1 was transformed into late-LTD, if early-LTD was induced in a second 
independent synaptic pathway S2 during the inhibition of PDE by rolipram, supporting 
the interaction of processes of synaptic tagging during RLTD.  
Although the mechanism of action of different forms of LTP is well understood, 
signalling cascades for LTD still remain poorly understood. I therefore delineated the 
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pathway for the possible mechanism of action of rolipram during the reinforcement of 
early-LTD. I could show that extracellular signal-regulated kinase (ERK1/ERK2) cascade 
is recruited during RLTD. Inhibition of the ERK signaling cascade with specific inhibitors 
of mitogen-activated protein kinases (MAPK), U0126 or PD98059 prevented the 
maintenance of RLTD. I further investigated the specific pathways by which ERK1/ERK2 
is activated during RLTD. Thus MAPK-activation was triggered during RLTD by the 
synergistic interaction of NMDA-receptor- and D1/D5-receptor-mediated Rap/B-Raf 
pathways but not by the Ras/Raf-1 pathway in adult hippocampal CA1 neurons, which 
was revealed by the use of pathway-specific inhibitors, manumycin for Ras/Raf-1 
pathway and lethal toxin-82 (LT-82) for Rap/B-Raf pathway. Thus for the first time I 
report that PDE4B3 could represent a process-non-specific PRP which regulates the 
synthesis of either LTP- and/or LTD- plasticity-related proteins (PRPs). 
Next, I was interested to investigate the question of what exactly is the putative 
nature of the synaptic tag? Are there specific ´tags´ for LTP and LTD? I studied the role 
of two promising candidates: Calcium/calmodulin-dependent protein kinase II (CaMKII) 
and mitogen- activated protein kinases (MAPK) on the setting of a synaptic tag during 
LTP and LTD. First I could confirm the results obtained from other laboratories that 
CaMKII or MAPK inhibition during the induction blocks the maintenance of LTP/LTD. 
However, I found that CaMKII or MAPK inhibition after the induction of LTP/LTD had no 
effect on the maintenance of the processes. 
In a next series of experiments I have investigated whether CaMKII can mediate 
the setting of the synaptic tags in LTP or LTD. Induction of late-LTP in S1 followed by 
early-LTP in S2 and in presence of CaMKII inhibitor, KN-62 prevented processes of 
synaptic tagging during LTP while application of KN-62 did not affect synaptic tagging 
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during LTD. It means setting of tags in LTP is CaMKII mediated while in LTD it is 
independent of CaMKII. 
  If CaMKII mediates the setting of synaptic tags in LTP, but not during LTD, the 
question was which kinase mediates the setting of the LTD-specific tags? By using two 
mitogen-activated protein (MAP) kinase kinase 1 (MKK1 or MEK) inhibitors, U0126 and 
PD98059, I could find that setting of LTD tag is mediated by MAPK. Thus LTP tagging is 
specifically mediated by CaMKII and LTD tagging by MAPK. 
Having determined the specifity of LTP- and LTD-specific tags I was now 
interested to find out the implication of tag-specificity for processes of cross-tagging. I 
could confirm the findings obtained in LTP/ LTD tagging, that CaMKII and MAPK 
mediates the setting of LTP /LTD-specific tags respectively in cross-tagging.  
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1. Introduction 
 
 1.1. Learning and memory 
One of the most important features of the mammalian central nervous system is 
its capacity for processing and storing information. Learning involves the acquisition of 
new information; memory is the retention of, and ability to recall information, personal 
experiences, and procedures (skills and habits) (Squire, 2004). The neural basis of 
memory is usually studied indirectly by monitoring the effects of brain damage on 
subsequent cognitive abilities or by measuring neural activity in terms of the 
hemodynamic, magnetic, or electrical field changes. At the beginning of 20th century 
Cajal (Jones, 1994b;Jones, 1994a) proposed that neuronal networks are not 
cytoplasmically continuous, but communicate with each other at distinct junctions, which 
Sherrington named ´synapses´ (Sherrington CS, 1906). External events are represented 
in the brain as spatio-temporal patterns of activity within preexisting neuronal circuits. 
Processes involved in learning and memory formation must therefore occur within 
preexisting neuronal circuits. The physical representation of a memory is referred to as 
the engram or memory trace (Dudai, 1996;Dudai, 2004). 
Although there is considerable information regarding the properties of memory 
formation and decay, studying the physical manifestation of memory remains difficult, 
beginning with a determination of where do memories reside. One of the most intensive 
searches to localize memory traces-or engrams-within the brain was initiated by Karl 
Spencer Lashley in the 1920's (Bruce, 2001). Lashley set out to determine the effect of 
various brain lesions on learning in rats. At the time, Lashley framed his work on the 
generally accepted belief that, the engram could be located in specific areas of the 
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neocortex based on the Broadman’s cytoarchitectural maps. However, the memory 
deficits were not localized to specific brain regions, suggesting that the memory traces 
were distributed throughout the cortex (Thompson, 1991;Thompson and Kim, 1996). 
 
1.2. Classification of memory  
In subsequent research, psychologists have distinguished several types of 
memory and have determined that there is considerable localization of function that was 
missed in Lashley’s work. We now know that different types of information require the 
engagement of different neural systems. Two major subdivisions of memory are 
declarative (explicit) and nondeclarative (implicit). Declarative memory, memory for facts 
and events, is associated with awareness and intention to recall. It is generally rapidly 
acquired, flexible, and prone to distortion (Cohen and Squire, 1980;Squire, 2004;Squire 
et al., 1993). Nondeclarative memory includes priming, motor skill and emotional 
memory. It is nonconscious, slowly acquired (except for priming), and inflexible (Squire, 
2004).  
Declarative memories rely on structures in the medial temporal lobe, including the 
hippocampus and the entorhinal, parahippocampal, and perirhinal cortices (Squire et al., 
1993). Lesions to these structures produce deficits in declarative memory tasks (Scoville 
and Milner, 2000;Scoville and Milner, 1957;Zola-Morgan et al., 1986;Squire et al., 
1993;Squire and Alvarez, 1995). Declarative memory can be further subdivided into 
episodic memory, involving recollections associated with a time and place, and semantic 
memory, which is the recollection of facts without the environmental and temporal 
context. Patients with bilateral medial temporal lobe lesions show both anterograde and 
retrograde amnesias (Scoville and Milner, 2000;Scoville and Milner, 1957). They cannot 
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acquire new episodic memories nor retrieve episodic memories stored shortly prior to 
the time of lesion. They can, however, retrieve declarative memories learned in the more 
distant past, suggesting that the storage of such information may depend, at least 
temporarily, on intact and functional medial temporal lobes. A significant role for the 
hippocampus in declarative memory was identified following neuropsychological 
research involving a human patient that had undergone bilateral lesions of both the 
hippocampus and surrounding cortical structures (Scoville and Milner, 1957). The 
removal of large sections of his temporal lobes including hippocampus left "H.M." unable 
to form any new personal memories, but his tragic loss revolutionized the field of 
neurobiology and made "H.M." the most-studied individual in the history of brain 
research.   
Another type of memory associated with awareness involves the short-term 
retention of a perceptual representation and is termed working memory. Working and 
declarative memory are dissociable because amnesic patients experience severe 
explicit memory deficits but normal working memory, and patients with parietal or frontal 
lobe lesions show poor working memory but normal explicit memory (Warrington and 
Weiskrantz, 1971). 
 
1.3. The Hippocampus  
The hippocampus is widely considered to be critical for the initial storage of 
declarative memories. It receives extensive input from neocortical systems and feeds  
information back to those same systems (McClelland et al., 1995). It has been 
suggested that the hippocampus provides a compressed trace for the temporary linking 
of component neocortical traces that must be activated together to read out the memory 
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in its entirety. The hippocampus plays a fundamental role in episodic memory, the kind 
that will let us remember a pleasant dinner party years later. Unlike our memory of facts 
and events, however, our spatial memory appears to be confined to the hippocampus. 
This structure seems to be able to create a mental map of space with the help of “place 
cells” (Nakazawa et al., 2004). 
The hippocampus, named for its resemblance to the sea horse (hippo= horse, 
kampos= sea monster; Greek) is formed by two interlocking sheets of cortex and in 
cross-section has a well defined laminar structure with layers visible, where rows of 
pyramidal cells are arranged. The different cell layers and sections are defined by the 
series of connections made. The information from the visual, auditory, and somatic 
associative cortices arrives first at the parahippocampal region of the cortex, and then 
passes through the entohorinal cortex and then on to the hippocampus proper. 
 
1.3.1. Trisynaptic loop of the hippocampus  
Within the hippocampus, the information passes through three distinct regions in 
succession. The hippocampus proper is composed of regions with tightly packed 
pyramidal neurons, mainly areas CA1, CA2, and CA3. (“CA” stands for Cornu Ammonis, 
or Horn of Ammon. The reference is to the ram’s horns of the Egyptian God Ammon, 
whose shape these three areas together roughly resemble). This makes what is called 
the trisynaptic circuit or trisynaptic loop of the hippocampus. Information enters this one-
way loop via the axons of the entorhinal cortex, known as perforant fibres (or the 
perforant path, because it perforates or penetrates through the subiculum and the space 
that separates it from the dentate gyrus). These axons make the loop’s first connection, 
with the granule cells of the dentate gyrus. From these cells, the mossy fibers in turn 
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project to make the loop’s second connection with the dendrites of the pyramidal cells in 
area CA3. The axons of these cells divide into two branches. One branch forms the 
commissural fibers that project to the contralateral hippocampus via the corpus 
callosum. The other branch forms the Schaffer collateral pathways that make the third 
connection in the loop, with the cells in area CA1 (Fig.1). 
                 
      
Fig. 1.  Schematic representation of major intrinsic connections of the mammalian hippocampal 
formation (adapted from Amaral and Witter, 1995). EC, entorhinal cortex; DG, dentate gyrus; MS, medial 
septum; LS, lateral septum; CA1 and CA3, fields of Ammon’s horn; SUB, subiculum; PaS, parasubiculum; 
PrS, presubiculum. 
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1.3.2. Hippocampus, an ideal structure for investigating synaptic plasticity 
Hippocampus is one of the useful structures for brain slice preparation and for 
investigating synaptic plasticity. The main reason is because of its structure, that allows 
a slice to  be cut  whilst preserving a large number of neurons and their interconnecting 
axons (Andersen et al., 1969;Amaral and Witter, 1989). The dendritic structure of the 
three main hippocampal cell types and their interconnecting axons lay in a single plane. 
This plane is oriented normal to the ventricular surface and to the longitudinal axis of the 
hippocampus. The lamellar structure allows slices to be taken without destroying the 
neurons together with their dendrites and axons. The highly organized and laminar 
arrangement of synaptic pathways with its extensive connections makes the 
hippocampus (Fig.1, adapted from (Amaral and Witter, 1989)) a convenient model for 
studying synaptic function in vitro and in vivo (Andersen et al., 1969;Amaral and Witter, 
1989).   
Brain slices offer a variety of novel opportunities, the most obvious being visual 
inspection. Depending upon the brain region, histological landmarks can be seen with an 
ordinary dissecting microscope. In many ways the tissue can be seen in a gross 
microscopic slide. This allows visual control of electrode placement. It is also possible to 
direct electrodes to known parts of a given cell. For example, in the hippocampus, an 
electrode may be placed in the apical or basal dendritic tree of pyramidal cells at known 
distances from the soma to record the activity of a small group of synapses. 
                      
                                            
Hippocampal slices in vitro also allow a comparison of the effectiveness of 
proximal and distal synapses to the same cell to be made. A great advantage is the lack 
of anaesthesis. This is of obvious importance for many studies on neuronal excitability, 
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but is also invaluable for many pharmacological studies. Furthermore, in the slice 
preparation, the influence of the blood brain barrier is removed. The ability to change the 
tissue concentration of interesting molecules at will provides good experimental control 
of the preparation. In addition to the temperature and oxygen concentration, the pH, 
ionic concentration and hormonal levels can be changed at will. The slice neurons are 
consequently under less synaptic bombardment than cells in the intact brain. Other 
modulating influences (neuromodulators, biological clocks, hormones) are also absent. 
The acute hippocampal slice preparation has been widely used to study the cellular 
mechanisms underlying activity-dependent forms of synaptic plasticity such as long-term 
potentiation (LTP) and long-term depression (LTD).   
 
1.4. Hebbian learning 
Learning and memory involve ongoing adaptations of brain circuitry throughout 
the life time in response to the environment and are generally thought to result from 
alterations in synaptic connectivity within the central nervous system (HEBB, 1959;Iriki et 
al., 1989). The synaptic connectivity changes create new networks or circuits that are 
believed to represent newly acquired memories. Hebb (1949) increased our 
understanding of how networks of neurons might store information with the provocative 
theory that memories are represented by reverberating assemblies of neurons. Hebb 
recognized that a memory so represented cannot reverberate forever and that some 
alteration in the network must occur to provide integrity both to make the assembly a 
permanent trace and to make it more likely that the trace could be reconstructed as a 
remembrance. Neurons communicate with each other only at synapses, the activity of 
the assembly or network is most easily altered by changes in synaptic function. Hebb 
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(1949) formalized this idea in his famous book ´The Organisation of Behaviour´ in what 
is known as Hebb's Postulate: 
  "When an axon of cell A is near enough to excite cell B and repeatedly or 
persistently takes part in firing it, some growth process or metabolic change takes place 
in one or both cells such that A's efficiency, as one of the cells firing B, is increased."  
Hebb's Postulate is very close to a modern-day definition of long-term potentiation 
(LTP). Bliss and Lomo first reported that brief tetanic stimulation of the perforant path in 
anesthetized rabbits increased the efficacy of synaptic transmission measured as 
changes of the population excitatory post-synaptic potential (EPSP) recorded 
extracellularly in the dentate gyrus. This prolonged increase in synaptic efficacy after a 
brief high-frequency stimulation of afferent fibers was named long-term potentiation 
(Bliss and Lomo, 1973). LTP is considered as a cellular correlate of learning and 
memory (Bliss and Collingridge, 1993).  
The effectiveness of LTP as a mechanism for information storage would be 
severely limited if processes that decrease synaptic strength did not also exist. In area 
CA1 of the rat hippocampus, prolonged periods of low-frequency afferent stimulation 
elicit a long-term depression (LTD) that is specific to the stimulated input. Dunwiddie and 
Lynch discovered long-term depression (LTD) that was found to occur at the synapses 
between the Schaffer collaterals and the CA1 pyramidal cells in the hippocampus 
(Dunwiddie and Lynch, 1978). LTD is defined as ‘persistent decrease in synaptic 
efficacy after a relatively short episode of low-frequency stimulation’ (LFS) (Bear and 
Malenka, 1994;Braunewell and Manahan-Vaughan, 2001). Since the work of Hebb, 
1949 and the discovery of LTP and LTD (Bliss and Lomo, 1973;Dunwiddie and Lynch, 
1978), these theoretical connections among neurons that strengthen as a result of 
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activity are referred to as Hebb synapses. The contention that LTP and LTD might serve 
as a memory storage device stemmed, at least in part, from its discovery in the 
hippocampus, a structure that is critical to the formation of certain types of memories.   
 
1.5. Properties of LTP and LTD 
Basic properties of LTP and LTD include input-specificity, associativity, 
cooperativity, and late-associativity. LTP and LTD are input-specific in the sense that it is 
restricted to activated synapses rather than to all of the synapses on a given cell. This 
feature of LTP is consistent with its involvement in memory formation. If activation of one 
set of synapses led to activation of all other synapses-even inactive ones-being 
potentiated, it would be difficult to selectively enhance particular sets of inputs, as is 
presumably required for learning and memory. Another important property of LTP and 
LTD are associativity. As noted, weak stimulation of a pathway will not by itself trigger 
LTP or LTD. However, if one pathway is weakly activated at the same time that a 
neighbouring pathway onto the same cell is strongly activated, both synaptic pathways 
undergo LTP or LTD. This selective enhancement of conjointly activated sets of synaptic 
inputs is often considered a cellular analog of associative or classical conditioning. More 
generally, associativity is expected in any network of neurons that links one set of 
information with another. The third basic property of LTP is synaptic cooperativity, i.e. 
LTP can be induced either by strong tetanic stimulation of a single pathway, or 
cooperatively via the weaker stimulation of many. It is explained by the presence of a 
stimulus threshold that must be reached in order to induce LTP. Late-associativity is a 
novel property of LTP and LTD. It describes intersynaptic interventions within a time 
frame of a few minutes to a few hours (Frey and Morris, 1997;Frey and Morris, 
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1998b;Frey and Morris, 1998a). More clearly, a weak protein synthesis-independent 
early-LTP/-LTD in one synaptic input can be transformed into a late, protein synthesis-
dependent form, if a protein synthesis-dependent late-LTP/-LTD is induced in the 
second synaptic input preceded by the weak events in the first synaptic input (weak 
before strong) within a specific time frame (Frey and Morris, 1998a;Frey and Morris, 
1998b;Kauderer and Kandel, 2000;Sajikumar and Frey, 2004a). 
 
1.5.1. Multiple Phases of LTP and LTD 
Brief high-frequency stimulation of the CA3-CA1 synapses can result in LTP, 
which can be divided into several temporal phases characterized by different underlying 
mechanisms. In general, it is divided into induction, expression and maintenance. The 
initial induction phase of LTP i.e. so named ‘posttetanic potentiation’ (PTP) with a 
duration of several seconds to minutes is characterized by presynaptic mechanisms, i.e. 
transient increase in transmitter release. PTP is followed by a ‘short-term potentiation’ 
(STP) with a duration up to one hour. Postsynaptic events like activation of transmitter 
receptors by local protein kinases (e.g. CaMKII, tyrosine kinase) (Dobrunz et al., 
1997;Huang, 1998)  are responsible for the maintenance of that phase. STP can be 
followed by at least two further phases: early-and late-LTP (Matthies et al., 1990;Huang, 
1998). Early-LTP is a transient form of LTP which lasts 2-3 h in vitro and 7-8 h in vivo, 
while late-LTP lasts for 8-10 h in vitro and days or even months in intact animals 
(Abraham and Bear, 1996;Abraham, 2003) (Fig. 2).   
The different forms of LTP can be specifically induced by distinct stimulus 
protocols in acute slices in vitro (Frey et al., 1993;Huang and Kandel, 1994). A single 
high-frequency stimulus train of distinct stimulation strength can induce early-LTP, but 
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such a protocol is normally not sufficient to induce late-LTP. The induction of late-LTP, 
on the other hand, requires repeated or stronger trains of high-frequency stimulation. 
Processes specifically involved in early- and late- phases of LTP require different cellular 
signaling pathways.  
 
Fig.  2.  The multiple phases of LTP. See text for a detailed description. 
 
The early-phase of LTP is transient and protein synthesis- independent induced 
by second messenger cascades, activated by Ca2+ influx, and maintained by activated 
kinases like CaMKII, tyrosine kinase, (Malenka and Nicoll, 1999;Soderling and Derkach, 
2000). Late-LTP begins gradually during the first 2-3 h and can last for 6-10 h in 
hippocampal slices in vitro and for days to months in vivo (Krug et al., 1989;Frey et al., 
1995;Otani and Abraham, 1989;Abraham et al., 2002;Kandel, 2001;Reymann et al., 
1985). A further major difference between early-LTP and late-LTP is that late-LTP 
requires protein synthesis (Krug et al., 1984;Frey et al., 1988;Otani et al., 1989). 
Application of suppressors of RNA-translation during LTP-induction resulted in a 
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decremental early-LTP while late-LTP was prevented (Krug et al., 1984;Stanton and 
Sarvey, 1984;Deadwyler et al., 1987;Abraham and Kairiss, 1988;Frey et al., 1988;Frey 
et al., 1996;Mochida et al., 2001).  
The phases and mechanisms of LTD are less extensively studied as compared to 
LTP. Recently it was reported that LTD within the hippocampal CA1 region in vitro 
shares similar properties like LTP (Sajikumar and Frey, 2003;Sajikumar and Frey, 
2004a). It was shown that different forms of LTD can be induced depending on the 
induction protocol, in a way as it is the case for the different LTP phases. A reliable long-
lasting LTD (late-LTD) up to 8 h can be induced using a strong low-frequency stimuation 
(SLFS) consisting of of 2700 pulses. Early-LTD, a transient form of LTD lasting less than 
2-3 h could be induced using weak low-frequency stimulation (WLFS) consisting of 900 
pulses. Like in LTP, early-LTD is protein synthesis-independent while late-LTD is 
dependent on ongoing protein synthesis (Sajikumar and Frey, 2003). The 
posttranslational modification of protein-phosphorylation or dephosphorylation of serine 
and threonine residues is usually considered essential for the initiation and maintenance 
of long-term potentiation (LTP) and long-term depression (LTD) in neural plasticity. 
 
1.6. Cellular mechanisms of LTP and LTD 
1.6.1. The involvement of protein kinases and phosphatases 
Protein phosphorylation is a key biochemical process involved in synaptic 
plasticity that operates through a tight balance between the action of protein kinases and 
protein phosphatases (PPs), which plays an important role in regulating synaptic 
plasticity in the mammalian hippocampus. 
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Long-lasting changes in synaptic strength, such as LTP, require intertwining 
biochemical cascades for their induction and maintenance. Induction of early-phase LTP 
(early-LTP) in the CA1 region of the hippocampus requires Ca2+ influx through the 
NMDA-type glutamate receptor (N-methyl-D.-aspartate-Receptor) to activate 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) (Lisman and Zhabotinsky, 2001). 
To convert early-LTP into late-phase LTP (late-LTP), inhibition of protein phosphatase 1 
(PP1) is essential to prolong CaMKII activation and phosphorylation of downstream 
substrates (Blitzer et al., 1995;Colbran and Brown, 2004). PP1 is inhibited during late-
LTP by stimulation of Ca2+/calmodulin-dependent adenylyl cyclases, raising cAMP levels 
to activate protein kinase A (PKA) (Wong et al., 1999;Nguyen and Kandel, 1996). Thus, 
activation of CaMKII combined with inhibition of PP1 "gates" early-LTP into late-LTP at 
least in juvenile animals (Atkins et al., 2005), but in  adult animals this pathway is 
achieved via a heterosynaptic stimulation of dopaminergic and glutamatergic receptors 
in CA1.  
 
1.6.2. The role of Ca2+/calmodulin-dependent protein kinase type II 
Calcium/calmodulin-dependent protein kinase II (CaMKII) - a major member of  
the postsynaptic density - is a Ca2+/calmodulin-activated dodecameric enzyme, which is 
necessary for LTP induction (Malenka et al., 1989;Silva et al., 1992). It is persistently 
activated by stimuli that elicit LTP, and can, by itself, enhance the efficacy of synaptic 
transmission. The analysis of CaMKII autophosphorylation and dephosphorylation 
indicates that this kinase could serve as a molecular switch that is capable of long-term 
memory storage (Lisman and McIntyre, 2001;Giese et al., 1998). Consistent with such a 
role, mutations that prevent persistent activation of CaMKII block LTP, experience-
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dependent plasticity and behavioral memory (Silva et al., 1992). These results make 
CaMKII a leading candidate in the search for the cellular and molecular basis of 
memory.  
The Lisman model of LTP (Lisman and McIntyre, 2001) proposes that patterns of 
synaptic activity that produce low levels of NMDA receptor activation and small increase 
in intracellular Ca2+ depress synaptic strength via a cascade of protein phosphatase 
activation (Mulkey et al., 1993). This cascade of protein phosphatase activation is 
thought to entail a Ca2+- and calmodulin-dependent activation of calcineurin, that 
dephosphorylates the PP1 regulatory protein inhibitor-1 (Mulkey et al., 1994). 
Dephosphorylation of inhibitor-1 activates PP1 that in turn dephosphorylates CaMKII. In 
contrast, stronger levels of NMDA receptor activation and larger increase in intracellular 
Ca2+ induce LTP by increasing levels of autophosphorylated CaMKII via a simultaneous 
activation of CaMKII and downregulation of PP1. In the model, a large increase in Ca2+ 
is thought to suppress PP1 activation by stimulating Ca2+- and calmodulin-sensitive 
isoforms of adenylate cyclase (AC) and by activating PKA that suppresses PP1 
activation by opposing calcineurin-mediated dephosphorylation of inhibitor-1.  
A major target for Ca2+ is CaMKII, and among its many actions are the 
phosphorylation of GluR1 at serine 831 (which increases the channel conductance of 
the AMPA receptor;(Lee et al., 2000)), and the insertion of the receptor into the 
postsynaptic membrane through an indirect mechanism; (Hayashi et al., 2000). From a 
network perspective, the multiple effects of activated CaMKII define it as a ´node´, a 
point where a signal is split and directed to multiple targets (Schmitt et al., 2005). 
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1.6.3. The interaction of three major postsynaptic signaling pathways in LTP 
Ca2+/calmodulin protein kinase II (CaMKII), mitogen-activated protein kinase 
(MAPK), and adenosine 3′,5′-cyclic monophosphate (cAMP)-dependent protein kinase 
(PKA) are all required for the induction of LTP (Frey et al., 1993;English and Sweatt, 
1997;Bortolotto and Collingridge, 1998). The influx of Ca2+ through N-methyl-D-
aspartate-type receptors (NMDA-R) or voltage-dependent Ca2+ channels (VDCC) can 
engage signaling cascades that activate these kinases. MAPK and CaMKII can promote 
the phosphorylation of each other, and MAPK is required for an increase in CaMKII 
levels produced by LTP-inducing stimulation (Giovannini et al., 2001). PKA activity 
promotes CaMKII phosphorylation by indirectly inhibiting the protein phosphatase PP1, 
which would otherwise limit the degree or persistence of CaMKII activation by 
dephosphorylating the kinase (Atkins et al., 2005). The phosphorylation and inhibition of 
CaMKII by PKA is likely to be involved in modulating the balance between cAMP- and 
Ca2+-dependent signal transduction pathways (Matsushita et al., 2001). Though PKA 
was initially identified as having an important signaling role in the protein synthesis-
dependent late stages of LTP (Frey et al., 1993), more recent evidence suggests that 
PKA also provides a mechanism for suppression of protein phosphatase activation in the 
early stages of LTP induction (Blitzer et al., 1995;Winder et al., 1998;Blitzer et al., 1998). 
Activation of the cAMP-PKA signaling pathway regulates both activity-dependent 
changes in synaptic strength and CaMKII phosphorylation in a chemical LTP induction 
protocol (Yamamori et al., 2004). Adenylyl cyclase (AC), protein phosphatase 2b (PP2b), 
(also called calcineurin); I-1P, phosphorylated protein phosphatase inhibitor-1, Ras, 
Rap1, Raf-1, B-Raf, and MAPK/ERK kinase (MEK) are all components of the MAPK 
cascade. 
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1.6.4. Role of MAPK signalling in synaptic plasticity 
In mammalian cells, three major groups of MAPK have been identified: 
extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38 
MAPK. It is well documented that ERK is typically stimulated by growth-related signals, 
whereas the JNK and p38 MAPK cascades are activated by various stress stimuli (Kelly 
et al., 2003). Studies have indicated that MAPK are expressed abundantly in the central 
nervous system (CNS) and that ERK is involved in long-lasting neuronal plasticity, 
including long-term potentiation and memory consolidation (English and Sweatt, 1997).  
The ERK cascade, like the other MAPK cascades, is distinguished by a 
characteristic core cascade of three kinases. The first kinase is a so-called MAPK kinase 
kinase (MAPKKK, Raf-1 and B-Raf in the erk cascade) which activates the second, a 
MAP kinase kinase (MAPKK, mitogen-activated protein (MAP) kinase kinase 1 (MKK1 or 
MEK) in the ERK cascade), by serine/threonine phosphorylation. MAPKKs (MEKs) are 
dual specificity kinases which in turn activate a MAP kinase (p44 MAPK = ERK1, 
p42MAPK = ERK2) by phosphorylating both a threonine and a tyrosine residue. The 
ubiquitous Raf-1 pathway is activated by Ras, which is stimulated by growth factor 
tyrosine kinase receptors, PKC also activates this pathway by interacting with either Ras 
or Raf-1. Activation of Raf-1 leads to activation of MEK and consequently the ERKs. The 
Ras/Raf-1 pathway is inhibited by PKA, which prevents Raf-1 activation and attenuates 
its activity. In an important breakthrough, Gibson and coworkers discovered that cAMP 
can be positively coupled to ERK activation in neurons via Rap-1 and B-Raf (Widmann 
et al., 1999). The B-Raf pathway is stimulated by cyclic AMP dependent protein kinase 
(PKA) and signals through the Ras homolog, Rap1. 
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 There is also strong evidence that activation of MAPK is necessary for late-LTP 
and long-term memory (English and Sweatt, 1997). The first suggestion that ERK 
participates in LTP was provided by the observation that mRNA levels for ERK2 was 
elevated in dentate granule cells 24 h after induction of LTP at the perforant path 
granule cell synapse in vivo (Thomas et al., 1994). A similar profile of mRNA expression 
after LTP induction was noted for both B-Raf and Raf-1, which is consistent with the 
activation of either a Ras- or a Rap-dependent pathway upstream of ERK activation 
during LTP. ERK appears to be critical for expression of both NMDA receptor-dependent 
and NMDA receptor-independent LTP in area CA1, because delivery of LTP inducing 
stimulation in presence of MEK inhibitors attenuates LTP. Additionally, MAPK has been 
shown to be required for long-term memory (Adams and Sweatt, 2002). Inhibition of 
MAPK impairs long-term (spatial and fear conditioning), but not short-term memory 
(Blum et al., 1999). 
 
1.6.5. Role of Protein kinase C  
Protein kinase C (PKC) is a heterogeneous family of ten or more isoforms which 
plays an important role in neuronal signal transduction. Isoforms from all subclasses are 
prominently expressed in the rat hippocampus, as demonstrated by immunoblot with 
isozyme-specific antisera: conventional (Ca2+/diacylglycerol (DAG)-dependent), novel 
(Ca2+-independent, DAG-dependent), and atypical (Ca2+/DAG-independent). In addition, 
the zeta isoform is also found as the free, constitutively active catalytic domain, protein 
kinase Mzeta (PKMζ) (Hernandez et al., 2003;Ling et al., 2002).  
Inhibitors of protein kinase C block different phases of hippocampal long-term 
potentiation (Reymann et al., 1988a;Reymann et al., 1988b). PKC activation is not 
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essential for the initial phase of LTP, but is a necessary condition for a medium and a 
late, protein synthesis-dependent phase in this monosynaptic pathway, i.e. for the 
maintenance of synaptic LTP (Reymann et al., 1988a;Reymann et al., 1988b). But 
contrary to these views on the subject some results show that postsynaptic PKC is 
essentially involved in both the initial induction and the subsequent maintenance of LTP, 
(Wang and Feng, 1992). 
PKC isoform consists of an amino-terminal regulatory domain, containing an 
autoinhibitory pseudosubstrate sequence and second-messenger binding sites, and a 
carboxy-terminal catalytic domain (Nishizuka, 1995;Ohno and Nishizuka, 2002). PKC is 
normally held in an inactive basal state by interactions between these two domains. 
Second messengers activate PKC by binding to the regulatory domain and causing a 
conformational change that temporarily releases the autoinhibition. 
PKM, in contrast, consists of an independent PKC catalytic domain, which, 
lacking PKC’s autoinhibitory regulatory domain, is autonomously active (Schwartz, 
1993). In brain, only a single isozyme, the atypical ζ, forms a stable PKM (Sacktor et al., 
1993). In LTP, PKMζ increases by new protein synthesis through increased translation 
from a PKMζ mRNA, producing the independent ζ catalytic domain (Hernandez et al., 
2003). The persistent activity of PKMζ is both necessary and sufficient for maintaining 
LTP (Ling et al., 2002). 
  
1.6.6. cAMP-dependent protein kinase (PKA) and synaptic plasticity 
 
Cyclic-AMP dependent protein kinase (PKA) is a serine-threonine kinase that has 
been strongly implicated in the expression of specific forms of long-term potentiation 
(LTP), (Frey et al., 1993;Huang and Kandel, 1994) and LTD, (Nguyen and Woo, 2003) 
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and hippocampal long-term memory. The principal target for cAMP in mammalian cells 
is cAMP-dependent PKA, which is ubiquitously expressed and mediates intracellular 
signal transduction and intercellular signal transmission in invertebrates and vertebrates.  
The hippocampal cAMP/PKA signalling cascade is principally activated by two 
mechanisms. The first involves calcium and calmodulin (Ca/CaM). Influx of calcium 
stimulates Ca/CaM-sensitive adenylyl cyclase, which synthesises cAMP (Eliot et al., 
1989). One route of Ca2+ influx is through NMDA receptors. Activation of these 
receptors, can increase cAMP levels in area CA1 of the hippocampus (Chetkovich et al., 
1991). The second mechanism for activation of cAMP/PKA signalling involves binding of 
chemical transmitters and hormones to their receptors, followed by stimulation of 
adenylyl cyclase by guanine nucleotide-binding regulatory proteins (G-proteins) (Tang 
and Gilman, 1991). These G-proteins interact with adenylyl cyclase on the inner 
membrane surface to activate the production of cAMP.  
The dependence of late-LTP, in hippocampal slices and behavioral memory, on 
PKA activity suggests that increasing cAMP signaling might increase behavioral memory 
by raising the probability that long-lasting synaptic plasticity would occur after synaptic 
stimulation (Barad et al., 1998). Administration of cAMP analogs such as Sp-cAMPS 
alone can cause long-lasting potentiation in rats that occludes subsequent electrical 
induction of late-LTP (Frey et al., 1993), suggesting that simply elevating cAMP 
throughout the hippocampus or brain might occlude rather than enhance synapse-
specific strengthening. Given the significant role of cyclic nucleotides in signal-
transduction pathways, it is not surprising that their metabolism and synthesis is highly 
regulated. Such metabolism is achieved by a large number of enzymes, the 
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phosphodiesterases (PDE), which catalyze the conversion of cAMP and cGMP into 5 -
AMP and 5 -GMP, respectively, via hydrolysis of the 3 -phosphoester bonds. 
 
1.7. Phosphodiesterases 
Cyclic nucleotide phosphodiesterases (PDE) are a large family of enzymes 
composed of at least 14 transcription units, many with alternately spliced isoforms. PDEs 
are comprised of three domains: an N-terminal regulatory domain (residues 1-151 in 
PDE4B), a catalytic domain (residues 152-489 in PDE4B) and a C-terminal domain 
(residues 490–568 in PDE4B). N-terminal domains of most PDE families contain unique 
regulatory domains harboring binding sites for small messenger molecules such as 
Ca2+/calmodulin, cGMP and/or recognition sites for protein kinases including the 
Ca2+/calmodulin-dependent kinase and the protein kinases A. The catalytic domain is the 
most conserved domain among the PDE families. The PDEs have been grouped into 
seven families based on their regulation and substrate specificity, two of which, type IV 
and type VII, have cAMP as their nearly exclusive substrate.  
The PDE4 isozymes are cAMP-specific, high-affinity PDEs. Members of this 
family are found in many tissues in both soluble and membrane-associated forms and 
are abundant in the central nervous system. PDE4A and PDE4B are expressed at 
relatively high concentrations in hippocampus, cerebral cortex and striatum and 
represent the majority of the membrane-bound form of PDE4 in these brain regions. 
Multiple isozymes have been identified, and at least four separate genes exist, which are 
highly conserved across several mammalian species. The PDE4 isozymes are regulated 
by phosphorylation and by binding cAMP. In addition, expression of certain PDE4 genes 
is regulated significantly by activation of the cAMP intracellular pathway. 
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Ahmed and Frey identified a specific type IV phosphodiesterase gene, PDE4B3, 
the first cAMP-specific phosphodiesterase to be associated with LTP in hippocampal 
CA1 area in vitro (Ahmed and Frey, 2003). They showed that PDE4B3 is modulated 
during LTP phases. Its activation is NMDA-receptor dependent and its transcription is 
transiently up-regulated 2 h after tetanization. Protein expression peaks 6 h after LTP 
induction and is rapidly down-regulated at 8 h, whereas cAMP levels decrease during 
LTP phases. Immunohistochemical studies identified that the majority of type IV 
phosphodiesterase protein staining is localized to the cell bodies and dendrites of 
neurons in hippocampal CA1. But in contrast with area-CA1, PDE4B3-levels in area 
dentata are characterized by a translational, but not transcriptional regulation within the 
first 8 h of LTP. Spatial-temporal changes of PDE4B proteins after LTP-induction occurs 
within the area dentata and was restricted to the soma protein fraction, whereas the 
substrate, cAMP-levels fluctuate in different compartments, depending upon possibly 
modulatory inputs. These results may add further support to the hypotheses that 
different hippocampal structures exhibit different processes in maintaining LTP. 
Moreover PDE4B3 mRNA is not translocated during LTP out of the soma into dendrites 
of area CA1, PDE4B proteins and cAMP-levels change in different tissue fractions may 
have a role in synaptic plasticity and cellular memory formation. Phosphodiesterases 
inhibitors can increases the cAMP levels by decreasing their breakdown. Rolipram is a 
well-documented isozyme-selective inhibitor of PDE4.   
 
1.7.1. Rolipram 
The type 4 cAMP-specific phosphodiesterases (PDE4s) are Mg2+-dependent 
hydrolases that catalyze the hydrolysis of 3', 5'-cAMP to AMP. Since the first finding that 
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the antidepressive drug 4-[3-(cyclopentoxyl)-4-methoxyphenyl]-2-pyrrolidone (rolipram) 
specifically inhibits the cAMP-specific PDE4, selective inhibition of PDE types has 
received particular attention in connection with the development of novel drugs. 
Rolipram is a PDE inhibitor which is selective for the Ca2+/ calmodulin-independent and 
cAMP-specific isozyme of PDE4 (Beavo, 1988). Rolipram is particularly interesting 
because many pharmaceutical companies are devising a rolipram-like drug that targets 
the brain's memory centers, to improve memory and to alleviate diseases like 
alzheimers.  It has been found that rolipram increases cAMP levels in vitro (Donaldson 
et al., 1988) and in vivo (Schneider, 1984). Administration of cAMP analogs can induce 
late-LTP (Frey et al., 1993). In contrast to the artificial raise of cAMP by the analogs 
used in the latter study, PDE-inhibitors maintain the basal cAMP concentration within a 
physiological range by inhibiting their metabolism (Barad et al., 1998) However rolipram 
has been associated with side effects, such as emesis and nausea. Although it is not 
certainly clear whether these side effects are caused by direct interaction between 
rolipram and the PDE4 or by separate effects on central nervous system, but, recent 
investigations indicate that the described side effects are caused by interaction of 
rolipram with high-affinity rolipram binding site (HARBS), one of the two pharmacological 
distinct conformational states of PDE4 isoenzymes, while several therapeutically 
relevant effects of PDE4 inhibitors are related to inhibition of PDE4 in its low-affinity 
rolipram binding conformation. Therefore, extensive studies have been performed to 
develop rolipram-like drugs, which lack these side effects but retain PDE4-inhibitory 
properties by increasing the specificity of the inhibitors for the low-affinity rolipram 
binding site. 
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1.7.2. Rolipram binding site 
  Rolipram was found to bind in the same site as cAMP. The pyrrolidinone group of 
rolipram could adopt two different orientations to fit the electron density. The phenyl 
group is sandwiched between the side-chains of Phe446 and Ile410. Asn395 and 
Tyr233 formed the bottom of the pocket. The methoxy group was completely buried at 
the back of the binding site in a small pocket made up of Tyr403, Tyr233, Thr407, 
Pro396, Gln443, Asn395, Ile410 and Trp406. The cyclopentoxy group was oriented at 
the front of the pocket, partially solvent-exposed, but in close proximity to Phe414, 
Phe446, Met411, Met431, Ser442, and Gln443. The methoxy and cyclopentoxy oxygen 
atoms each made hydrogen bonds with the side-chain NH2 of Gln443. The hydrogen 
bonds were in the same plane as the phenyl group. The orientation of the Gln443 side-
chain was fixed by an additional hydrogen bond between its carboxyl oxygen and the 
hydroxyl group of Tyr403. Rolipram binds to the high-affinity and low-affinity states of the 
protein with a Ki of 5-10 nM and 350-400 nM, respectively. The high-affinity binding state 
requires both the N-terminal domain and the catalytic domain, while the low-affinity 
binding state requires only the catalytic domain. The truncated protein (152-528) used 
for structural studies described below contains only the low-affinity binding state 
(Ki=350–400 nM). Well characterised mutations that affect rolipram binding are primarily 
located in the binding pocket and are predicted to be in contact with cAMP substrate 
(Atienza et al., 1999). 
 
1.7.3. Rolipram and memory 
Rolipram, a selective inhibitor of type 4 cAMP-specific phosphodiesterase 
(PDE4), produces an increase in brain cAMP levels via the inhibition of its degradation 
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(Schneider, 1984). Behavioral studies show that rolipram inhibits locomotor activity and 
rearing induced by methamphetamine and produces biphasic effects on schedule-
controlled behavior, increasing response rate at lower doses and decreasing response 
rate at higher doses (O'Donnell and Frith, 1999;Iyo et al., 1995). Rolipram also exhibits 
antidepressant-like effects in animal models and in patients with depressive disorders 
(O'Donnell and Frith, 1999;O'Donnell, 1993;Hebenstreit et al., 1989). 
Imanishi and colleagues (Imanishi et al., 1997) found an ameliorating effect of 
rolipram on learning and memory impairment in rodents. Rolipram also has been shown 
to reverse the impairment of either working memory or reference memory induced by the 
muscarinic receptor antagonist scopolamine (Egawa et al., 1997;Imanishi et al., 
1997;Zhang and O'Donnell, 2000).  
Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits 
produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat 
hippocampus thus PDE4 is likely to be an important link between the cAMP/PKA and 
MEK/ERK signalling pathways in the mediation of memory (Zhang et al., 2004). In 
mouse hippocampal CA1, rolipram reinforced a transient into a lasting potentiation 
(Barad et al., 1998). The dependence of late-LTP, in hippocampal slices and behavioral 
memory, on PKA activity suggests that increasing cAMP signaling might increase 
behavioral memory by raising the probability that long-lasting synaptic plasticity would 
occur after synaptic stimulation. Moreover it was speculated that rolipram, by generally 
raising cAMP concentration throughout the brain, may enhance memory by a different 
mechanism perhaps by consolidating changes at recently stimulated synapses "tagged" 
by endogenous signalling mechanisms (Barad et al., 1998).Thus PDE mediates the 
synthesis of PRPs in an early-LTP input which otherwise is incapable of synthesising 
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proteins. A fundamental question in the synaptic plasticity field is how these newly 
synthesized proteins are specifically targeted to the tetanized synapses without affecting 
nearby un-tetanized synapses. Are the gene products produced in the cell body and 
transported specifically to, or are they produced locally at the tetanized synapses? 
Synaptic tagging hypothesis provides a clear answer to these questions (Frey and 
Morris, 1998a;Frey and Morris, 1997).  
 
1.8. Synaptic tagging 
Gene expression and protein synthesis that mediate the long-term changes of 
LTP generally take place in the cell body or, for protein synthesis, in dendritic 
compartments, i.e. far away from the stimulated synapse. However also late-LTP is 
synapse-specific, i.e. LTP induced at one synapse does not propagate to adjacent 
inactive synapses. Therefore, the cell is posed with the difficult problem of synthesizing 
plasticity-related products in the nucleus or cell body, but ensuring they only reach 
synapses that have received LTP-inducing stimuli. As a possible solution to this 
targeting problem, the 'synaptic tag hypothesis' (Frey and Morris, 1997;Frey and Morris, 
1998a) proposed that the persistence of LTP is mediated by the intersection of two 
dissociable events. The first event involves the generation of a local ‘synaptic tag’ at 
specific synapses in association with and perhaps causally related to the induction of 
LTP. The second involves the production and diffuse distribution of ‘plasticity-related 
proteins’ (PRPs) that are captured and utilised only at those synapses possessing a tag. 
The ´synaptic tagging´ hypothesis describes a mechanism, how input specificity is 
achieved during a protein synthesis-dependent stage (Frey and Morris, 1997;Frey and 
Morris, 1998a;Frey and Morris, 1998b;Martin and Kosik, 2002). Late-LTP was induced 
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on one pathway (S1), and the protein synthesis inhibitor anisomycin was then bath 
applied just before the second pathway (S2) was tetanised. Normally, only early-LTP 
would be induced and late-LTP inhibited in the presence of anisomycin. However, the 
LTP induced on S2 remained potentiated for up to 8 h post-tetanus. Similarly, “weak” 
tetanic stimulation that normally induces only early-LTP could be ‘transformed’ into late-
LTP heterosynaptically if a “strong” tetanus was delivered to an independent input to the 
same population of CA1 pyramidal cells shortly before or shortly after the weak tetanus 
(Frey and Morris, 1998b). Similar findings reflecting synaptic capture, but at the single-
cell level, have been observed in Aplysia neurons in culture (Martin et al., 1997).  
The synaptic-tag hypothesis also makes a number of other predictions. One is 
that the successful induction of late-LTP at a synapse will depend on the intersection of 
two parameters: the decay time course of the tag and the intracellular kinetics of 
relevant protein synthesis and distribution; however, which of these is initiated first is 
unimportant. The synaptic-tag hypothesis can also help explain the observation that the 
induction of early-LTP on one pathway precludes the induction of further early-LTP on 
that same pathway for a period thereafter, but that early-LTP can be induced on a 
pathway displaying late-LTP. Young et al showed that late-LTP-associated transcription 
and the expression of prolonged potentiation can be differentially regulated by previous 
synaptic activity (Young and Nguyen, 2005). 
The synaptic tag hypothesis allows us to think about the properties of LTP in a 
new way. The usual way of thinking about associativity is in terms of the heterosynaptic 
interaction of two or more inputs, over a short time scale (less than one second), 
mediated via the voltage dependence of the NMDA receptor. The synaptic tag idea 
points to a secondary form of associativity in which one input can influence another over 
 35
a much longer time scale (about 90 min). Moreover depotentiation after 5 min can 
effectively reset the tag but 10 or 15 min is unable to reset the tag complex (Sajikumar 
and Frey, 2004b). Input specificity is usually considered in relation to the 
compartmentalization of Ca2+ transients within dendritic spines and thus local Ca2+-
dependent phosphorylation. However, the input specificity of late-LTP is determined by 
local tags that sequester proteins manufactured a relatively long way away. Finally, 
persistence can be variable; whether or not early- LTP is transformed into late-LTP will 
depend on the history of activation of the neuron, during both the immediate past and 
the time that follows shortly after. This history includes heterosynaptic activation of 
aminergic as well as glutamatergic input pathways, the former being particularly 
important in freely moving animals. Recently Sajikumar and Frey (Sajikumar and Frey, 
2004a) have reported that synaptic tagging occurs during LTD with a similar time course 
as in LTP. Synaptic tagging has been described also by other laboratories and is now a 
widely studied model for processes involved in the associative interaction of neurons in 
neuronal nets during memory formation (Frey and Morris, 1997;Frey and Morris, 
1998a;Martin, 2002;Martin and Kosik, 2002;Sajikumar and Frey, 2004a;Navakkode et 
al., 2004;Sajikumar et al., 2005b;Fonseca et al., 2004;O'Carroll and Morris, 2004;Young 
and Nguyen, 2005). Synaptic tagging encourages us to think of LTP and LTD in the 
context of the entire neuron; it is a step towards a better understanding of the cellular 
and molecular basis of memory. 
 
1.8.1. The identity of the 'synaptic tag´ 
What is the molecular identity of the putative synaptic tag? The tag does not 
necessarily has to be a single molecule, however, experimental data indicate that the 
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tag must satisfy a number of criteria: (1) the tag is induced in a protein synthesis-
independent manner, (2) the tag possesses a lifetime of 1-2 hr, (3) the tag is induced 
both by early-LTP/ -LTD and by late-LTP/ -LTD, (4) the tag is induced in an input-specific 
and physically immobile manner, (5) the tag interacts with the proteins required for late-
LTP/-LTD to facilitate capture/tagging, and (6) distinct tags are created as a 
consequence of LTP/LTD induction. A number of possible postsynaptic modifications 
have been enumerated as candidates for the synaptic tag (Frey and Morris, 
1998a;Martin and Kosik, 2002). One possible candidate is the phosphorylated state of 
an early-LTP-associated kinase with duration of about four to six hours. For example, it 
is known that LTP requires the activation of various kinases, such as CaMKII, while LTD 
requires the activation of various phosphatases, such as calcineurin (CaN).  Another 
possibility could be a change in cytoskeletal dynamics. There is evidence that 
cytoskeletal changes occur during LTP and LTD, these changes, along with changes in 
the molecular motors that interact with the cytoskeleton, could form the mechanism 
behind the tagging process. Alterations in membrane receptor number, molecular 
architecture of the synapse, localized protein degradation, or conformational changes in 
particular molecules, among other possibilities, could also form the basis for the tag. 
BDNF, Sp-cAMPS, and DHPG which are sufficient to induce late-LTP may also provide 
some clues to the nature of the tag (Hegde, 2004). The atypical protein kinase C known 
as protein kinase Mζ (PKMζ), the persistent activity of which requires protein synthesis, 
has been shown to be another possible candidate. But recently we could identify PKMζ 
as the first LTP specific plasticity related protein, not a tag molecule (Sajikumar et al., 
2005b). Inhibition of PKA before and during the tetanic stimulation blocked the late-LTP 
in the CREB transgenic mice, suggesting that PKA is required for tagging the synapse.  
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Another potential candidate for a synaptic tag that has recently received 
significant attention is the actin microfilament network at the synapse. The actin network 
in neurons is extremely dynamic, and these dynamics have been shown to change with 
activity. Studies have shown that ubiquitin-mediated proteolysis of the regulatory subunit 
of PKA results in a persistently active kinase, and that this degradation involves the 
transcriptional induction of an ubiquitin carboxy-terminal. Together, these findings raise 
the possibility that local activation of PKA and local regulation of the ubiquitin-
proteasome pathway can serve as synaptic tags that combine with transcriptional events 
(for example, the induction of the ubiquitin carboxy-terminal hydrolase) to produce 
persistent increase in  synaptic strength due to local protein synthesis (Hegde, 2004). 
 
1.8.2. Cross-tagging 
Recently, the 'synaptic tagging' model has been expanded to include interactions 
between LTP and LTD, referred to as synaptic ´cross-tagging´. In cross-tagging, a late 
LTP/-LTD in one synaptic input S1 transforms the opposite, protein synthesis-
independent early LTP/-LTD in an independent input S2 into its long-lasting form. Thus 
heterosynaptic induction of either LTD/LTP on two sets of independent synaptic inputs 
S1 and S2 can lead to late-associative interactions: early-LTD in S2 was transformed 
into a late-LTD, if late-LTP was induced in S1 (Fig. 3). The synthesis of process-
independent PRPs by late-LTP in S1 was sufficient to transform early- into late-LTD in 
S2 when process-specific synaptic tags were set. Cross-tagging not only expands the 
repertoire of interactions between pathways but raises the fundamental question of 
whether the function of a newly synthesized PRP is to generally prolong the action of a 
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weak stimulus, or whether there are separate PRPs to specifically prolong potentiation or 
depression. 
Based on synaptic tagging- and cross-tagging-hypotheses, Susumu Tonegawa 
proposed a “clustered plasticity model” for long term memory engrams in which he 
proposed, for long-term memory engrams, the memory representation at the single-cell 
level is composed of a pattern of synaptic potentiation and depression clustered in one 
or a few dendritic branches, and not dispersed to all the dendritic compartments. In a nut 
shell, the inevitable diffusion of newly made proteins through dendrites from the site of 
synthesis and the similarity of the protein repertoire accompanying late-LTP and late-
LTD provide a molecular basis for the tagging and cross-capture hypothesis for late-LTP 
and late-LTD. 
                                    
                   
Fig. 3.  Model for conversion of early-LTD to late-LTD via synaptic capture (from Kelleher et al, 
2004b).  
When four tetanic trains are delivered to a synapse (1), an LTP tag (2) is formed at the synapse (this tag 
may also be induced by a single tetanic train), and translation and transcription (3 and 4) are induced. The 
 39
newly synthesized proteins can support expression of both late-LTP and late-LTD and are thus presumed 
to include products necessary for late-LTP, late-LTD, or both. These newly synthesized proteins are also 
available to other synapses, but only the synapse bearing the LTP tag captures the proteins necessary for 
late-LTP, causing that synapse to express late -LTP and the accompanying structural changes (5). If a 
second synapse then receives weak-LFS (1′) in close temporal proximity to stimulation of the first 
synapse, transcription and translation are not induced, but an LTD tag is created (2′). This synapse then 
captures the proteins necessary for late-LTD (which were synthesized in response to late-LTP induction at 
the first synapse), resulting in structural changes (5′) and expression of late-LTD at the second synapse. A 
similar process also occurs when early-LTP is converted to late-LTP. Since the tag has a half-life of 
approximately 1-2 h, the weak stimulation can occur either before or after the strong stimulation (from 
Kelleher et al, 2004). 
 
1.9. Aims of this dissertation  
In the first part of my dissertation the main aim was to study the role of rolipram, a 
selective cAMP phosphodiesterase inhibitor, on late plastic events during functional CA1 
plasticity in vitro in hippocampal slices. First, I studied the role of PDE inhibition on LTP, 
and could show that rolipram reinforces an early form of LTP into a late form of LTP 
(RLTP). In a further series of experiments, I studied the properties of RLTP like protein-
synthesis and NMDA-receptor dependence and whether RLTP can interact with 
processes of synaptic tagging. Further, I studied whether RLTP was influenced by 
inhibitors of the D1/D5 receptor.  
We have earlier shown that PKMζ represents a plasticity-specific-protein (PRP) 
which is both necessary and sufficient for LTP, but not for LTD. So my next main aim 
was to study whether the action of PDE is specific like PKMζ or it can act as a process-
unspecific PRP necessary for mediating processes of both plasticity forms. So I studied 
the role of PDE inhibition on LTD and its properties. Further I could also show that RLTD 
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can interact with processes of synaptic tagging which is dependent on D1/D5-receptors 
unlike in case of RLTP. In addition I was interested to investigate the mechanism by 
which rolipram reinforces early-LTD into late-LTD. For that, I studied whether RLTD 
requires the activation of ERK1/ERK2. Then I further delineated the specific pathways 
by which ERK1/ERK2 is activated during RLTD i.e. whether the activation of 
ERK1/ERK2 occurs by a Rap/PKA or Ras/Raf-1 pathway. 
The second part of my dissertation deals with the question of what exactly is the 
putative nature of the synaptic tag. I studied the role of two promising candidates 
CaMKII and MAPK during the processes of synaptic tagging in LTP and LTD. I could 
show that CaMKII plays an important role in mediating the setting of tags in LTP, but not 
in LTD. MAPK was shown to mediate setting of tags in LTD, but not for LTP. Further I 
confirmed these data with cross-tagging experiments using CaMKII and MAPK 
inhibitors. 
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2. Materials and methods 
 
2.1. Hippocampal slice preparation  
All experiments were performed in right hippocampal slices (400 µm thick) 
prepared from 7 weeks old male Wistar rats (total number of animals: 310). The animal 
was stunned by a blow behind the foramen magnum and decapitated (cervical 
dislocation). Following decapitation, the skin and fur covering the skull were cut away 
and an incision was made on both sides. The bone covering the brain was prised away 
and dura removed before transferring the brain into chilled and carbogenated (carbogen: 
gas consisting of 95% O2 and 5% CO2) artificial cerebrospinal fluid (ACSF) (about 4°C) 
(Reymann et al., 1985). Cold solution was used to slow down the metabolism of the 
tissue, to limit the extent of excitotoxic and other kinds of damage occurring during the 
preparation of slices (Reymann et al., 1985). Chilling the petridish and tissue slicer 
support on ice may help reduce tissue deterioration. Brain is placed in a petriplate on 
filter paper and the cerebellum and frontal cortex is dissected away. Divide the 
remaining part of the brain in the central sulcus by a deep cut using a scalpel and the 
hippocampal commissure was cut and the right hippocampus was taken out on to the 
stage of manuel tissue chopper (Cambden, UK), and 400 µm thick slices were cut at 70° 
transverse to the long axis from the middle third of the right hippocampus. After 
sectioning, the slices were picked up by a wet artist’s brush, floated in a petri dish 
containing the cooled and carbogenated ACSF, and immediately transferred to the nylon 
net in the experimental chamber maintained at 32oC by a wide bored pipette. One of the 
critical points which elapse between the removal of the brain and the placing of the 
slices in the chamber is that slice preparation should be performed in less than 3 min 
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and favourably at a temperature of 4oC to minimize cellular metabolism and to avoid 
irreversible intracellular phase changes. It is well known from studies investigating 
ischemic and/or hypoxic influences on brain function that ischemic episodes with a 
duration of longer than 3 min as well as glutamate receptor-dependent calcium release 
during preparation can result in an irreversible prevention of protein synthesis in nervous 
tissue (Erdogdu et al., 1993;Djuricic et al., 1994;Djuricic et al., 1995). Furthermore, to 
obtain these morphological and functional characteristics we use always a cleaned new 
razor blade for each preparation of not more than 3-4 slices from a single hippocampus 
from one animal to obtain hippocampal CA1-slices (dorsal part of the right hippocampus 
of males). When slices are taken out with proper care the responses, observed on 
stimulation are similar to those seen in intact animals. Slices were incubated within an 
interface chamber (Fig. 4) at 32°C (carbogenated incubation medium contained 124 mM 
NaCl, 4.9 mM KCl, 1.2 mM KH2PO4, 2.0 mM MgSO4, 2.0 mM CaCl2, 24.6mM NaHCO3, 
10 mM D-glucose). Supply of oxygen was achieved by controlling the gas flow over the 
surface of the slice (carbogen flow rate: 32 l/h) thus preventing the drying out of the 
slices (Sajikumar et al., 2005a). 
Slices were preincubated for at least 4 h, a quite unusual long period, but it has 
been shown by the following reasons to be critical for a stable long-term recording as 
well as the study of late plasticity for up to 16 h, under conditions which resemble the 
functionality of studies in vivo.Temperature conditions are also crucial for mammalian 
slice preparation in vitro. Studies from Micheva and Smith revealed that subphysiological 
temperatures might dramatically affect functional plasticity in mammalian presynaptic 
terminals (Micheva and Smith, 2005). 
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Fig. 4. Interface chamber and electrical set-up for long term extra cellular recording. 
(A) An overview of recording chamber and its electrical set-up. (B) Interface chamber with manipulators. 
(C) Microscopic view of a hippocampal slice located with electrodes. 
 
Hippocampal slices in vitro are characterized by a very low spontaneous activity 
which may result from an almost ‘absolute rest’ during preincubation. Biochemical 
studies have shown that metabolic stability is reached in slices after 2-4 h, i.e., 
metabolite levels require 2-4 h to stabilize, and these levels are then maintained for at 
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least 8 h of incubation (Whittingham et al., 1984). This includes parameters for the 
activity of enzymes, second messengers, pH, and others. Interestingly, the value for bio-
active molecules which stabilizes at a very low level, if strong electrical stimulation was 
not delivered to the tissue. We suppose that in addition to processes of the acute slice 
preparation, low electrical activity may result in the delayed but prolonged metabolic 
stability at a low level after about 4 h if no stimulation is applied to the tissue. This may 
lead to a reduction of PRPs to an amount near zero if the half life of the proteins is 
considered with about 2 h. Thus, starting with functional experiments after a 
preincubation time of 4-5 h may rectify all slices and neurons to a low but very 
comparable basal metabolic and plasticity level. Tetanization for instance, would then 
activate a machinery of processes ‘from zero’ (a situation never occurring in behaving 
animals) which is mechanistically more useful to determine time constants during plastic 
events, than it would be the case by using freely behaving untreated rats. If in intact rats 
protein synthesis is blocked by a pharmacological reversible inhibitor a similar situation 
as in slices can be created revealing similar time constants for early-LTP in vitro. 
Unfortunately, currently available reversible protein synthesis inhibitors reduce the 
synthesis of macromolecules in the intact animal for several hours, making this 
preparation probably unusable to directly study processes of synaptic tagging with the 
methods used so far. Thus, slice preparations represent an ideal, however also partially 
artificial model to determine properties of tagging and late-associativity. Although, most 
of the problems concerning brain slice incubation are known for a long time, most 
laboratories start their ‘physiological’ slice experiments after a very short preincubation 
period of even less than 1 h. Knowing the metabolic instability during that period we 
prolonged the preincubation of hippocampal slices to at least 4 h to obtain comparable 
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and more physiological results in describing functional processes in slice preparations. 
This requirement is supported by additional data such as measuring basal endogenous 
protein phosphorylation patterns and the translocation of different protein kinase C 
isoenzymes (α, β and γ) to the membrane as markers of their activation in tissue 
obtained from hippocampal slices in vitro or from intact, untreated rats. Studies revealed 
that only slices incubated in the same way as described here showed comparable 
patterns of phosphorylation and enzyme translocation as detected in the intact animal 
(Angenstein and Staak, 1997). Although one could argue that specific modifications of 
slice preparation may circumvent distinct problems raised above, to maintain the 
complex slice physiology at a level which allows reliable studies of functional plasticity 
favours a more simple method: to wait (Sajikumar and Frey, 2004a). 
Following the preincubation period, the test stimulation strength was determined for 
each input to elicit a population spike of about 40 % (for LTD studies) or 25 % (for 
studies conducted to investigate LTP) of its maximal amplitude determined by slice 
specific input-output relationship. For stimulation, biphasic constant current pulses were 
used. The baseline was recorded for at least 60 min before LTP/LTD induction. Four 0.2 
Hz biphasic, constant-current pulses (0.1 ms per polarity) were used for testing 1, 3, 5, 
11, 15, 21, 25, 30 min post-tetanus or 21, 25, 30 min post-LFS and thereafter once 
every 15 min up to 8 h. Since the two recorded parameters showed either similar time 
course in the experiments (if the population spike was not abolished after induction of 
LTD at all), for clarity only the fEPSP data are shown. A detailed description of the 
experimental protocol for the preparation, incubation and investigation of reliable rat 
hippocampal CA1 late-LTP/LTD is shown in Fig. 5 (Sajikumar et al., 2005a).  
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2.2. Experimental protocol 
           
 
Fig. 5. Experimental protocol for the preparation, incubation and investigation of reliable rat 
hippocampal CA1 late-LTP/LTD.  
The scheme represents a general protocol for how to perform experiments investigating long-
lasting functional plasticity in hippocampal slice preparations in vitro. (a) Slice preparation takes three 
minutes. In the first minute of the experiment the rat is killed by a blow to the back of the neck and the right 
hippocampus is removed. In the second and third minutes the hippocampus is cooled in carbogenated 
artificial cerebro-spinal fluid (ACSF) at 4°C, and three to four slices are cut and gently positioned in the 
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incubation chamber at 32°C. (b) In the next three to four hours the slices are pre-incubated at 32°C. (c) At 
this stage, electrodes are gently positioned in the slices and there is a rest period of 30 min. We use 
electrolytically, sharpened stainless steel electrodes(input resistance: 5 MΩ; AM-Systems, USA) that are 
cleaned with alcohol and ACSF shortly before they are gently and slowly positioned in the middle of the 
hippocampal slice (about 200 µm from the surface) to reach the neuronal area that has been best 
preserved (Pohle et al., 1986). We stimulate with biphasic constant current pulses to guarentee stable 
stimulation for the duration of the experiment. (d) Approximately four and half hours after slice preparation 
the parameters of stimulation are determined according to an input-output relatioship. At this time point the 
baseline recording begins. Recorded potentials were amplified by a custom made amplifier (INH, 
Magdeburg, Germany) (e) The baseline recording continues for one or two hours and can vary, for 
example, if the stability of baseline recordings has not yet been achieved or if pharmacological substances 
have been administered. During the baseline recording input-output stability should be should be checked 
at a few stimulus intensities. (f) Time point zero. At this point the LTP or LTD is induced. (g) For the next 6 
or 8 hours the recording takes place. Recording takes place at two points in the same neuronal population. 
Inset: positioning of electrodes in a transverse hippocampal slice to stimulate two separate synaptic 
inputs, S1 andd S2, to the same neuronal population. The population spike and the field EPSP are 
recorded. Anlog traces represent typical control potentials. The analog signals were then digitised using a 
CED 1401 A/D converter and analysed with custom-made software (PWIN, Magdeburg, Germany). (h) 
After 8 hours there is another 30 minutes of recording during which the input-output relationship is 
monitored and LTP or LTD is induced again to check the viability of the slice. The Time course shown 
here only represents the case for LTP or LTD in a synaptic input S1 and a stability control recorded in a 
second, independent input S2. 
 
All experiments were carried out in accordance with the European Communities 
Council Directive of 24th November 1986 (86/609/EEC). It is also certified that formal 
approval to conduct the experiments described has been obtained from the animal 
subjects review board of the institution/local government which can be provided upon 
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request. All efforts were made to minimize the number of animals used and their 
suffering. 
 
2.3. Stimulation Protocols: Induction of late-LTD, early-LTD, late-LTP and early-
LTP  
For inducing late-LTD, a strong low-frequency stimulation protocol (SLFS) which 
consisted of 900 bursts (one burst consisted of 3 biphasic, constant current stimuli at a 
frequency of 20 Hz, interburst interval: 1 s, i.e. f=1 Hz, stimulus duration 0.2 ms per half-
wave; a total number of stimuli of 2700) was found to be the most effective protocol 
(Sajikumar and Frey, 2003;Sajikumar and Frey, 2004a). This stimulation pattern 
produced a stable LTD in vitro for at least 8 h. For inducing a transient early-LTD a weak 
low-frequency stimulation protocol (WLFS) consisting of 900 pulses (f=1 Hz, impulse 
duration 0.2 ms per half-wave, a total number of stimuli of 900, as ever: biphasic, 
constant current stimuli) was determined to be the most efficient in inducing early-LTD 
(Sajikumar and Frey, 2003;Sajikumar and Frey, 2004a). Late-LTP was induced using 
three stimulus trains of 100 pulses (‘strong’ tetanus: f=100 Hz, stimulus duration 0.2 ms 
per polarity with 10 min intertrain-intervals) (Frey and Morris, 1997;Frey and Morris, 
1998b). In experiments with induction of early-LTP, a single tetanus with 21 pulses was 
used (`weak’ tetanus: f=100 Hz, stimulus duration 0.2 ms per polarity, population spike 
threshold stimulus intensity for tetanization (Frey and Morris, 1997;Frey and Morris, 
1998b). 
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2.4. The nature of field potentials 
In extracellular recording the potential difference is measured between two 
electrodes, one of which is placed within the tissue of interest and the other which is 
outside the tissue and acts as a ´reference electrode´. The voltage at the reference 
electrode is by convention zero. During activity of the nervous tissue the current ´I´ that 
flows between parts of a cell (due to movement of ions), through the external resistance 
´R´ produces a potential difference ´V´, therefore the change of potential against time 
can be recorded. The potential difference that can be recorded extracellularly due to the 
activity of one cell is very small. However, the laminated structure of the hippocampal 
formation, where many neurons are tightly packed together in the same orientation 
allows the recording of quite large responses. When many neurons are simultaneously 
activated, the change in the potential in each of them is in the same ´direction´ and thus, 
they summate. The absolute amplitude of the potentials is dependent on the value of the 
external resistance so that in an interface chamber, where the slices are partly 
surrounded by air (high resistivity) the potentials are much larger than in submerged 
chambers. Since field potentials are recorded from a population of neurons, changes 
can reflect not only changes in the amplitude of the responses in the individual cells but 
also the number of neurons involved and the synchrony of their activity. 
In the hippocampus two main types of field potentials are recorded: the field 
excitatory post synaptic potential (fEPSP) and the population spike (PS). At low 
stimulation intensities (below threshold), the fEPSP is a reflection of the individual 
EPSPs of the neurons as well as IPSPs due to feed forward inhibition. Above threshold, 
IPSPs due to recurrent inhibition and a component due to neuronal firing may also be 
present. Since inhibition usually occurs with a delay with respect to the onset of the 
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EPSPs, the slope of the fEPSP is considered to be a good measure of activity at the 
excitatory synapses, although the amplitude of the fEPSP shows similar changes. When 
measured in the dendritic region, the fEPSP is by convention negative (sink), whilst in 
the cell body layer the potential recorded is positive (source) (Bliss and Gardner-
Medwin, 1971;Bliss and Richards, 1971). The PS which is usually recorded in the cell 
body layer is a component potential, reflecting the changes in the potential due to the 
firing of the action potential by the neurons, superimposed upon the reversed fEPSP 
originating in the dendrites. The amplitude of the PS is a measure between the negative 
peak of the potential and the positive peak preceding it. Since action potentials are ´all-
or-none´ the PS reflects the number of neurons involved and the synchrony of their firing 
(Andersen et al., 1969). 
 
2.5. Pharmacology 
Rolipram (Tocris), a type IV-PDE inhibitor, was used at a concentration of 0.1 µM 
dissolved in ACSF and 0.1% dimethyl sulphoxide (DMSO). D-2-amino-5-
phosphonopentanoic acid (AP-5; Sigma) was used at a concentration of 50 µM 
(dissolved in ACSF) to block the NMDA-receptor. Anisomycin (Sigma), a reversible 
protein synthesis-inhibitor, was used at a concentration of 25 µM (a concentration that 
blocked at least 85% of 3H-leucine incorporation into hippocampal slices; (Frey et al., 
1991a)). The selective dopaminergic D1/D5-receptor SCH23390 was used at a 
concentration of 0.1 µM (Tocris; dissolved in ACSF). Emetine (Tocris Cookson) was 
used at a concentration of 20 µM (dissolved in ACSF and 0.1% DMSO). MEK inhibitor 
U0126 (Promega) was used at a concentration of 1µM (dissolved in DMSO to a stock 
concentration of 10 µM). PD 98059 (Calbiochem) was used at 10 µM concentration. 
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Manumycin A (Streptomyces parvulus (Calbiochem), a selective inhibitor for 
farnesyltransferase, was dissolved in 0.02% DMSO in ACSF. Lethal Toxin-82 (LT-82) 
(Clostridium Sordelli), donated by Prof. Michel Popoff, France was dissolved ACSF. 
For tag candidate search studies the CaMKII inhibitors KN-62 ((1-[NO-bis-1, 5-
isoquinolinesulfonyl]-N-methyl-L-tyrosyl- 4-phenylpiperazine)) and AIP (autocamtide-2-
related inhibitory peptide) (Calbiochem) was used at a concentration of 5 µM. It was 
prepared by dissolving in DMSO (the final concentration of DMSO was 0.1 %), as a 
stock solution (10 mM) and was stored at -20°C. The required volume containing the 
final concentration of 5 µM was dissolved in ACSF immediately before bath application. 
Stock solutions of MAPK antagonist, U0126, 2-(2-amino-3-methoxyphenyl)-4H-1-
benzopyran-4-one (PD98059) were prepared in DMSO at a 10 mM stock solution and 
the required volume containing the final concentration of 20 µM was dissolved in ACSF 
immediately before bath application.  
 
2.5. Statistics 
The average values of the population spike (mV) and  slope function of the field 
EPSP (mV/ms) per time point were subjected to statistical analysis (Wilcoxon signed 
rank test, when compared within one group or the Mann-Whitney-U-test when data were 
compared between groups (p<0.05 considered as being statistically significant 
different)). 
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3. Results 
 
3.1. Rolipram-induced reinforcement of early-LTP (RLTP) and its properties 
Induction of late-LTP in S1 (STET; Fig. 6A, filled circles) using high-frequency 
stimulation (HFS) resulted in late-LTP that was significantly different for 6 h, compared 
with the control input S2 (open circles). Control stimulation of S2 showed relatively 
stable potentials for the time course investigated. Induction of early-LTP in synaptic input 
S1 (Fig. 6B, filled circles) resulted in a transient statistically significant form of LTP with a 
duration of 2-3 h before returning to baseline values where the potentials remained 
stable for the time of recording. A control input S2 without application of high-frequency 
stimulation remained stable at baseline level for the whole experimental session (open 
circles in Fig. 6B). Application of rolipram, a phosphodiesterase (PDE) inhibitor 30 min 
before until 30 min after the induction of early-LTP in input S1 (Fig. 6C, filled circles) 
converted the transient early form of LTP into a statistically significant late form with a 
duration of at least 6 h (rolipram reinforced LTP or RLTP), the latest time point we have 
recorded (Fig. 6C, filled circles). Control responses obtained from S2 (open circles in 
Fig. 6C) remained stable at baseline levels. Analyses of the input-output relationship 
before the application of rolipram and tetanization and 6 h after LTP induction revealed 
no differences when compared with rolipram-untreated slices. A comparable EPSP-
spike-shift was seen in the tetanized input. The control input remained stable over the 
investigated 7 h. We also did not observed any effects of rolipram on LTP-induction by 
analysing the tetanization trains under the influence of the drug at the used 
concentration. Next, we investigated as to whether the PDE-inhibitor had to be present 
during the induction of early-LTP to be effective in generating RLTP or whether it would 
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have been sufficient to apply rolipram after the induction of early-LTP. In the latter case 
it could act via late-associative properties on the earlier tetanization of input S1 in a non-
specific way. Fig. 6D represents the time course of the Field EPSP when rolipram was 
applied shortly after the induction of early-LTP (15 min after tetanization in S1). In this 
case, rolipram was ineffective in affecting early-LTP (filled circles in Fig.  6D). Next, we 
examined whether NMDA-receptor activation was required for RLTP. As shown in Fig. 
6E, co-application of 50 µM AP-5 prevented the induction of early-LTP and RLTP. In this 
series, after recording a baseline for 50 min, AP-5 was applied for 10 min before co-
applied with rolipram for another 1h. The following series of experiments studied the 
possible requirement of macromolecular synthesis for RLTP. The reversible protein 
synthesis inhibitor anisomycin was applied 10 min before co-application with rolipram for 
a further 6h. Fig. 6F (filled circles) shows that anisomycin did not prevent early-LTP but 
RLTP, thus the reinforcement of early-LTP by rolipram seems to be protein synthesis-
dependent. In all series of experiments the control input S2 (open circles) was not 
influenced by the drugs or tetanization. 
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Fig. 6. Rolipram-induced reinforcement of early-LTP (RLTP) and its properties. 
(A) Time course of the slope of the Field EPSP after induction of late-LTP in S1 (filled circles, n=8). (B) 
Time course of the slope of the Field EPSP after induction of early-LTP in S1 (filled circles). Open circles 
represent a control stimulated synaptic input S2; n=8. (C) Transformation of early- into late-LTP by 
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rolipram. Application of rolipram, 30 min before stimulation of S1 (filled circles) with a tetanization protocol 
which normally would induce early-LTP (washout of the drug: 30 min after tetanization; open circles: 
control input); n= 7. (D) The same experiment as in (C) with the exception that rolipram was applied 15 
min after LTP-induction for 1 h; n=7. (E) The influence of the NMDA-receptor blocker AP-5 on RLTP: after 
recording a baseline for 50 min, AP-5 was applied for 10 min before co-applied with rolipram for another 
1h. Tetanization with a protocol which normally would induce early-LTP in S1 (filled circles) and control 
recording of S2 (open circles); n=7. (F) The same as in (E) but instead of AP-5, the reversible protein 
synthesis inhibitor anisomycin was applied 10 min before co-application with rolipram for a further 1 h; 
n=7.       
Analog traces always represent typical Field EPSPs 30 min before (dotted line), 30 min (hatched 
line) and 6 h (closed line) after tetanization of input S1 and corresponding control S2. Arrows indicate the 
time point of tetanization of the corresponding synaptic input. Triplet arrows indicates strong tetanisation 
(STET) while single arrows represent weak tetanisation (WTET) to induce early-LTP at the corresponding 
input. Bars represent the period of drug application. Scale bar: 3mV/3ms (valid for all single analog 
examples represented). 
 
3.2. PDE inhibition by rolipram and processes of synaptic tagging during LTP 
RLTP seems to mimic protein synthesis-dependent late-LTP. Thus the question 
arose as to whether processes of 'synaptic tagging' can be detected, since only those 
inputs showed RLTP in which early-LTP was induced together with the application of 
rolipram (see Fig. 6C). Thus, a first set of controls studied the possible interference of 
the subsequent induction of early-LTP in two separate synaptic inputs S1 and S2. As 
shown in Fig. 7A early-LTP of the two inputs was not influenced if the time interval 
between subsequent tetanization was 40 min. However, when early-LTP was induced in 
S1 followed by the application of rolipram 15 min after tetanization of S1, i.e. at a time 
point where rolipram was ineffective in affecting the potentiation in that input (see Fig. 
6D), and a subsequent induction of early-LTP in S2 was induced 40 min after 
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tetanization of S1 - but now under the influence of rolipram - both inputs S1 and S2 
paradoxically expressed late-LTP (Fig. 7B). We then investigated whether these 
rolipram-induced, associative prolongations of early-LTP require the synthesis of 
macromolecules. In the series shown in Fig. 7C we have repeated the experiment 
represented in Fig. 7B with one exception: here, emetine (5 min after tetanization of S1) 
was applied shortly before rolipram (15 min after tetanization). We have also tested a 
second, structurally different inhibitor of protein synthesis; anisomycin to confirm our 
results (Fig. 7D). Interestingly in these cases, under protein synthesis inhibition the 
associative reinforcement of early-LTP in S1 and S2 was prevented. These data support 
the involvement of phosphodiesterases in processes of 'synaptic tagging'. 
It has been shown recently, that protein synthesis-dependent processes of 
'synaptic tagging' in area CA1 require specifically the heterosynaptic activation of D1/D5-
receptors during induction (Sajikumar and Frey, 2004a). Thus, we were interested as to 
whether the action of rolipram still requires D1/D5-receptor-activation or as to whether 
PDE-processes act downstream of D1/D5-receptors. Therefore, we have now applied 
the selective D1/D5-receptor antagonist SCH23390 shortly before the application of 
rolipram (Fig. 7E) - in the same manner as in the set with anisomycin (Fig. 7D). As 
shown in Fig. 7E, 'synaptic tagging' and the expression of RLTP in the two inputs S1 and 
S2 was not negatively influenced by the blockers of the dopaminergic receptors 
supporting an action of the PDE downstream of the D1/D5-receptors. Interestingly, a 
tendency of enhanced potentiation was detected under these circumstances. 
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Fig.  7. PDE inhibition by rolipram and processes of synaptic tagging during LTP 
(A) Time course of the slope of Field EPSPs after subsequent induction of early-LTP in S1 (filled circles) 
and S2 (open circles) with a time interval between tetanization of S1 and S2 of 40 min; n=7. (B) 
Paradoxical transformation of early- into late-LTP in S1 (filled circles) by subsequent induction of RLTP in 
S2 40 min later (open circles). Same stimulation protocol as in (A) with the exception that 15 min after 
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tetanization of S1 rolipram was added to the bath medium for 1h before washout; n=7. (C) and (D) RLTP 
and synaptic tagging depends on protein synthesis. The same procedure as in (B), however, after the 
additional application of emetine 5 min after tetanization of S1; n=8. (D) represents the effect of a 
structurally different protein synthesis inhibitor, anisomycin on RLTP, suggesting a specific action on 
protein synthesis by the drugs used; n=7. (E) The action of rolipram is downstream of the D1/D5-
receptors. When SCH23390 was applied instead of anisomycin (as in (D)) neither the paradoxical 
transformation of early- into-LTP in S1 (filled circles) by subsequent RLTP-induction in S2 (filled circles) 
nor RLTP in S2 were blocked; n=7.   
Analog traces always represent typical Field EPSPs 30 min before (dotted line), 30 min (hatched 
line) and 6 h (closed line) after tetanization of input S1 or, in cases in which S2 was also tetanized, before 
or after the tetanization of that input. Single arrows represent weak tetanisation (WTET) to induce early-
LTP at the corresponding input. Bars represent the period of drug application. Scale bar: 3mV/3ms (valid 
for all single analog examples represented). 
 
3.3. Rolipram-induced reinforcement of early-LTD (RLTD) and its properties 
In a first control set of experiments we have induced late-LTD in a synaptic input 
S1 by the application of a strong low-frequency stimulation (SLFS) which resulted in 
robust late-LTD of the Field-EPSP in S1 with a duration of at least 6 h (Fig. 8A, filled 
circles). A separate, synaptic control pathway S2 (Fig. 8A, open circles) remained stable 
at baseline values. A statistically significant difference between S1 and S2 was observed 
for the measured 6 h after SLFS in S1. This type of LTD was protein synthesis-
dependent (Sajikumar and Frey, 2003;Sajikumar and Frey, 2004a). Induction of early-
LTD in synaptic input S1 (Fig. 8B, filled circles) resulted in  a transient early form of LTD 
with a duration of 2-3 h before returning to baseline values at which the potentials 
remained stable for the time of recording. A control input S2 (Fig. 8B; open circles) 
remained stable at baseline levels for the entire experimental session (statistically 
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significant different between S1 and S2 for 2 h after WLFS to S1). Application of rolipram 
(0.1 µM) 30 min before until 30 min after the induction of early-LTD in input S1 converted 
the transient form of early-LTD in to a statistically significant late form with a duration of 
up to 6 h (Fig. 8C, filled circles). Control responses from S2 remained stable at baseline 
levels (Fig. 8C, open circles). Analysis of the input-output relationship before the 
application of rolipram and WLFS and 6 h after LTD induction revealed no differences 
when compared with rolipram-untreated slices. A comparable and similar EPSP/spike 
shift was observed in the LTD-induced input. We then investigated whether the PDE 
inhibitor has to be present during the induction of early-LTD to be effective in generating 
RLTD or whether it is sufficient to apply rolipram after WLFS. As shown in Fig. 8D (filled 
circles) rolipram application 25 min after the induction of early-LTD in S1 was unable to 
induce RLTD in that input. The control input S2 again remained stable throughout the 
recorded time period of 6 h (Fig. 8D, open circles). 
 
3.4. Properties of rolipram-reinforced early-LTD 
We investigated whether NMDA-receptor activation is necessary for RLTD. After 
recording the baseline for 50 min, AP-5 (50 µM) was bath-applied for 10 min before 
being co-applied with rolipram for another 1 h (Fig. 8E). When WLFS was applied to S1 
(filled circles) in presence of AP-5 together with rolipram the induction of early-LTD as 
well as RLTD was prevented. In the next series of experiments we studied whether 
protein synthesis is required for the reinforcement of early- into late-LTD. Application of 
20 µM emetine (Fig. 8F) or 25 µM anisomycin (Fig. 8G) in a similar manner as in Fig. 8E 
prevented any lasting form of LTD in S1 (filled circles). Potentials in the control input 
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remained stable (open circles in Figs. 8F and G). Thus, reinforcement of early-LTD by 
rolipram was protein synthesis-dependent.  
               
-60 0 60 120 180 240 300 360
0
25
50
75
100
125
n=8
WLFS S1
Rolipram
Time(min)
Fi
el
d 
EP
SP
 (m
Vm
s-
1)
%
-60 0 60 120 180 240 300 360
0
25
50
75
100
125
Time(min)
Fi
el
d 
EP
SP
(m
Vm
s-
1)
% n=7
Rolipram
Anisomycin
WLFS S1
S1 S2
-60 0 60 120 180 240 300 360
0
25
50
75
100
125
Time (min)
Fi
el
d 
EP
SP
 (m
Vm
s-
1)
% n=7
WLFS S1
Rolipram
A P-5
S2S1
-60 0 60 120 180 240 300 360
0
25
50
75
100
125
n=7
WLFS S1
Rolipram
Time (min)
Fi
el
d 
EP
SP
 (m
Vm
s-
1)
 %
S1 S2
E F
-60 0 60 120 180 240 300 360
0
25
50
75
100
125
WLFS S1
n=4
Rolipram
Emetine
Time(min)
Fi
el
d 
EP
SP
(m
Vm
s-
1)
%
S1 S2G
-60 0 60 120 180 240 300 360
0
25
50
75
100
125
WLFS S1
Time (min)
Fi
el
d 
EP
SP
 (m
Vm
s-
1)
%
n=7
S1 S2
S1 S2
3mV
3ms
B
D
-60 0 60 120 180 240 300 360
0
25
50
75
100
125
n=10
Time (min)
Fi
el
d 
EP
SP
 (m
Vm
s-
1)
%
SLFS S1
C
A
S 1 S 2
 
Fig. 8. Rolipram-induced reinforcement of early-LTD and its properties. (A) Induction of late-LTD in 
S1 (filled circles) using a repeated LFS protocol (i.e., strong low-frequency stimulation (SLFS); broken 
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arrow) resulted in late-LTD which is significantly different for the 6 h investigated when compared with a 
control input S2. Control stimulation of S2 revealed relatively stable potentials for the time course 
investigated (open circles); n=10. (B) A WLFS protocol (broken arrow) was used which elicited transient 
early-LTD of the Field EPSP with a duration of 185-210 min; n=7. (C) Transformation of early- into late-
LTD by rolipram. Application of rolipram (0.1 µM) 30 min before WLFS of S1 (filled circles) that normally 
would induce early-LTD (washout of the drug, 30 min after WLFS; open circles, control input) ; n=8. (D) 
The same experiment as in (c) with the exception that rolipram was applied 25 min after LTD and elapsed 
for 1 h; n=7. (E) The influence of the NMDA receptor blocker AP-5 on RLTD. After recording a baseline for 
50 min, AP-5 (50 µM) was applied for 10 min before being co-applied with rolipram for another 1hour. 
WLFS in presence of AP-5 prevented the early-LTD (filled circles), the control recording of S2 remained 
stable during the recorded time period (open circles); n=7. (F) Same as in (E) but instead of AP-5, the 
reversible protein synthesis inhibitor anisomycin (25 µM) was applied 10 min before co-application with 
rolipram for an additional hour; n=7. (G) Represents the effect of a structurally different protein synthesis 
inhibitor, emetine (20 µM) on RLTD, suggesting a specific action on protein synthesis by the drugs used; 
n=4.   
The analog examples given in the figures represent adequate potentials 30 min before (dotted 
line), 30 min after (broken line) as well as 6 h after the induction of the event (here after induction of SLFS 
in S1; closed line) in input S1 and S2, respectively. Scale bar: 3 mV/3 ms (valid for all single analog 
examples presented). Broken arrows indicate the time point of low frequency stimulation. Bars represent 
the period of drug application. 
 
3.5. PDE inhibition by rolipram and processes of synaptic tagging during LTD 
Next, we studied whether the protein synthesis-dependent RLTD was 
characterized by processes of synaptic tagging, because only those inputs expressed 
RLTD which received WLFS, i.e. in which early-LTD was induced. RLTD was therefore 
input-specific and is dependent on protein synthesis. We have reported earlier that the 
induction of conventional early-LTD in two inputs S1 and S2 do not interfere with each 
other, (Sajikumar and Frey, 2004). For investigating the processes of synaptic tagging 
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during RLTD, early-LTD was induced in synaptic input S1, after 25 min rolipram (0.1 µM) 
was applied (a time point where it was ineffective in affecting the first input; see Fig. 8D) 
for 1 h. Fifty five min after induction of early-LTD in S1 (filled circles), early-LTD was 
induced in input S2 (open circles), but now it was under the influence of rolipram. 
Paradoxically, in both inputs a late form of LTD was observed (Fig. 9A) which supports 
our hypothesis that synaptic tagging takes place during RLTD. In the next series of 
experiments we investigated whether synaptic tagging in LTD in area CA1 required the 
heterosynaptic activation of glutamatergic and dopaminergic D1/D5-receptors. To 
investigate that, the experiment described in Fig. 9A was repeated with the exception 
that shortly before application of rolipram the D1/D5-receptor-specific antagonist 
SCH23390 (0.1 µM) was applied 10 min before being co-applied with rolipram (Fig. 9B). 
SCH23390 prevented synaptic tagging and the rolipram-induced transformtion of early- 
into late-LTD in both inputs S1 and S2. Thus, the action of rolipram in the hippocampal 
CA1 of adult rats was dependent on D1/D5-receptor activation. In a similar manner, co-
application of the protein synthesis inhibitors anisomycin or emetine with rolipram also 
prevented processes of synaptic tagging induced by rolipram and the transformation 
from early-into late-LTD (Fig. 9C and D). 
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Fig. 9. PDE inhibition by rolipram and processes of synaptic tagging during LTD 
 (A) Transformation of early- into late-LTD in S1 (filled circles) by subsequent induction of RLTD in S2 55 
min later (open circles; n=7). WLFS was induced in S1 and 25 min after WLFS of S1, rolipram was added 
to the bath medium for 1 h. (B) The same experiment as in (A) with the exception of the additional 
application of D1/D5 receptor antagonist SCH23390 (0.1 µM) 15 min after WLFS of S1 (n=9). Here 
synaptic tagging by RLTD is prevented. (C) and (D), experiment presented in (B) was repeated using 
anisomycin (25 µM; n=8) and emetine (20 µM; n=8), protein synthesis inhibition prevents synaptic tagging 
in RLTD. 
Analog traces always represent typical Field-EPSPs 30 min before (dotted line), 30 min (hatched 
line) and 6 hr (closed line) after WLFS of input S1, or in cases in which WLFS was delivered to S2. Broken 
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arrows indicate the time point of the WLFS of the corresponding synaptic input. Scale bar: 3 mV/3 ms 
(valid for all single analog examples presented). Bars represent the period of drug application. 
 
3.6. Reinforcement of early-LTD by rolipram through MAPK activation. 
Zhang et al. (2004) found in behavioral experiments a functional link between 
MAPK/ ERK and cAMP signalling pathways in the mediation of long-term memory, in 
which PDE4 is likely to be involved. Moreover, ERK activation is necessary for the 
persistent maintenance and expression of NMDA receptor-dependent LTD in area CA1 
of the adult hippocampus in vivo (Thiels et al., 1996). The main question arose if MAPK 
activation is also essential for RLTD? As shown in Figs. 10E and F, the MEK inhibitors 
U0126 (1 µM) or PD098059 (1 µM) effectively blocked RLTD, which suggests that 
MAPK mediate RLTD-processes. In each set of experiments a baseline was recorded 
for 50 min and then one of the MEK inhibitors, either U0126 (1 µM; Fig. 10E) or 
PD098059 (1 µM; Fig. 10F) was applied for 10 min before co-applied with rolipram for 
another 60 min. MEK inhibitors prevented RLTD without affecting early-LTD in S1 when 
WLFS was applied 30 min after application of rolipram to S1 (filled circles in 10E and F). 
The control inputs S2 in the two sets of experiments remained stable throughout the 
recorded time period (Fig. 10E and F, open circles).  
The previous sets of experiments revealed that MEK activation is essential for 
RLTD. Now the question arose which signaling cascade is involved in the activation of 
MEK? First, we have investigated the Ras-mediated cascade. Application of 
manumycin-A, a Ras inhibitor (2 µM), 10 min before co-application with rolipram for 30 
min prior to early-LTD did not prevent the expression of RLTD. i.e. the transformation of 
early- into late-LTD in input S1 (Fig. 10G, filled circles) excluding the Ras signaling 
cascade as a candidate for the activation of MEK during RLTD. The next series of 
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experiments were conducted to examine if the Rap-mediated pathway of activating MEK 
may take place in RLTD. Lethal Toxin-82 (LT-82; 200 ng/ml), an inhibitor of the Rap1-B-
Raf pathway, was applied in a similar manner as described in Fig. 10H. In contrast to 
manumycin-A, LT-82 blocked RLTD (Fig. 10G and H, filled circles). We can conclude 
that the prevention of RLTD was due to Rap1-B-Raf-inhibition by LT-82 because Ras 
inhibition by manumycin did not prevent RLTD. In both cases the control input S2 
remained stable at baseline levels throughout the recorded time period of 6 hr (Fig. 10G 
and H, open circles).  
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Fig. 10. The reinforcement of early-LTD by rolipram through MAPK activation  
(E) The influence of the MEK inhibitor, U0126 on RLTD (n=7). After recording a baseline for 50 min, 
U0126 (1 µM) was applied for 10 min before being co-applied with rolipram for another hour. WLFS in S1 
in presence of MEK inhibitor U0126 prevents RLTD (filled circles), control recording of S2 (open circles) 
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remained stable during the recorded period. (F) The same experiment as in (E) however instead of U0126 
a different MEK-inhibitor, PD98059 (1 µM; n=7) was applied, confirming the results obtained in (E). (G) 
Effect of Ras inhibition by mamumycin-A on RLTD (n=7). After recording a baseline for 50 min, 
mamumycin A (2 µM) was applied for 10 min before being co-applied with rolipram for another hour. 
WLFS in S1 in presence of manumycin had no effect on RLTD (filled circles), control potentials from S2 
remained stable (open circles). (H) Effect of Lethal Toxin-82 (LT-82; n=7) on RLTD. The same experiment 
as in (G) but with the presence of a Rap inhibitor LT-82 (200 ng/ml), which prevents the RLTD (filled 
circles).  
The analog examples given in the figures represent adequate potentials 30 min before (dotted 
line), 30 min after (broken line) as well as 6 h after the induction of the event (here after induction of SLFS 
in S1; closed line) in input S1 and S2, respectively. Scale bar: 3 mV/3 ms (valid for all single analog 
examples presented). Broken arrows indicate the time point of low frequency stimulation. Bars represent 
the period of drug application.  
 
3.7. Role of CaMKII and MAPK on LTP and LTD 
 
The role of CaMKII and MAPK on LTP was previously reported (Yang et al., 
2004;Bortolotto and Collingridge, 1998). We reproduced these experiments in our 
experimental conditions before investigating its role during the processes of synaptic 
tagging in LTP/LTD or in synaptic cross-tagging between LTP and LTD. 
Induction of late-LTP in S1 in presence of CaMKII inhibitor, KN-62 (open 
rectangle, 5 µM, Fig. 11A, filled circles) by using a STET resulted in early-LTP lasting 2-
3 h. We have used a very low concentration of 5 µM KN-62 since we were interested to 
investigate a concentration which resets the synaptic tags. The control inputs showed 
normal response over the investigated time period of 8h (Fig. 11A, open circles). We 
next investigated whether 5 µM KN-62 has any effect on LTP maintenance. As it is 
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shown in the Fig. 11B, application of KN-62 fifteen minutes after (for the next 1 h) the 
induction of LTP did not affect its maintenance (Fig. 11B, filled circles).  
We next investigated whether CaMKII inhibition by KN-62 has any role in LTD 
induction and its maintenance. Fig. 11C shows that late-LTD is dependent on CaMKII 
activation.  As it is shown, application of 5 µM KN-62 before and after the induction of 
late-LTD in S1 prevents the induction of LTD (Fig. 11C, filled circles). Interestingly the 
early form of LTD was also prevented leaving a depression lasting 45 min. In Fig 11D, 
similar to Fig. 11B we applied KN-62 fifteen minutes after (elapsed for the next 1 h) the 
induction of late- LTD. As it is shown in Fig. 11D neither the depressed synaptic input S1 
or the control input S2 did not showed any effect (Fig. 11D, filled and open circles).  
Next, we were interested to know the role of MAPK on LTP and LTD. We used a 
specific inhibitor of MAPK, U0126 at a concentration of 20 µM. In Fig. 11E, application of 
20 µM U0126, 30 min before and 30 min after the induction LTP in S1 prevents its late 
maintenance with out affecting the early phase of LTP lasting 2-3 h. Responses 
obtained from S2 (open circles) remained relatively stable potentials at control levels. 
Application of U0126 fifteen minutes after the induction of LTP for the next 1 h did not 
affect the maintenance  of potentiated synaptic input S1 or the control synaptic input S2 
(Fig. 11F, filled and open  circles). 
The last set of experiments in this series investigated the role of MAPK on LTD. 
As it is shown in Fig. 11G application of 20 µM U0126 before and after the induction of 
late-LTD in S1 prevents the induction of LTD (filled circles). Interestingly here the early 
form of LTD was also prevented like in case of late-LTD in presence of KN-62 shown in 
Fig. 11C. Application of U0126 fifteen minutes after (for the next 1 h) the induction of 
late- LTD did not affected either the depressed synaptic input S1 or the  control input S2 
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(Fig. 11H, filled and open circles) maintaining a stastically significant depression in S1 
up to 8 h. 
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Fig. 11. Role of CaMKII and MAPK on LTP and LTD.  
(A) Time course of the slope of the field EPSP after induction of late-LTP in S1 (filled circles). Open circles 
represent a control stimulated synaptic input, S2 (n = 4). Application of a CaMKII inhibitor KN-62 (open 
rectangle, 5 µM) 30 min before stimulation of S1 with a strong tetanization protocol that normally would 
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induce late-LTP (washout of the drug, 30 min after tetanization) is prevented resulting in an early-LTP. (B) 
The same experiment as in A with the exception that KN-62 was applied 15 min after LTP induction for 1 h 
(n = 4). (C) Application of the CaMKII inhibitor KN-62, 30 min before and after the induction of late-LTD in 
S1 prevented the induction of LTD (filled circles). Responses obtained from S2 (open circles) remained 
relatively stable potentials at control levels (n = 3). (D) The same experiment as in D with the exception 
that KN-62 was applied 15 min after LTD induction for 1 h (n = 4). (E) Time course of the slope of the field 
EPSP after the induction of late-LTP in S1 (filled circles) in presence of a MAPK inhibitor U0126 (filled 
rectangle, 20 µM, drug applied 30 min before and elapsed 30 min after  the induction LTD in S1). 
Responses obtained from S2 (open circles) remained relatively stable potentials at control levels (n = 6). 
(F) The same experiment as in E with the exception that U0126 was applied 15 min after LTP induction for 
1 h (n = 3). (G) Application of the MAPK inhibitor U0126, 30 min before and after the induction of late-LTD 
in S1 prevented the induction of LTD (filled circles). Responses obtained from S2 (open circles) remained 
relatively stable potentials at control levels (n = 4). (H) The same experiment as in F with the exception 
that U0126 was applied 15 min after LTD induction for 1 h (n = 4). 
Triplets of filled arrows indicate the time point of strong tetanization (STET) for inducing late-LTP 
and broken arrows represents strong low frequency stimulation (SLFS) of the corresponding synaptic input 
for inducing late-LTD. Analog traces represent typical Field EPSPs 30 min before (dotted line), 3 min 
(broken line) and 8 h (closed line) after STET or SLFS. 
 
3.8. Role of CaMKII and MAPK on synaptic tagging in LTP and LTD.  
An earlier set of experiments showed that 5 µM KN-62 or 20 µM U0126 prevented 
the late phase of LTP and LTD, if applied during their induction, whereas application of 
either CaMKII or a MAPK inhibitor after the induction of either LTP or LTD does not have 
any role in its maintenance, therefore it is possible to induce early-LTP/-LTD in the 
second synaptic input in presence of CaMKII or MAPK inhibitor without affecting the 
PRPs which is triggered by the induction of late-LTP/-LTD in the synaptic input S1 thus, 
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enable us to investigate whether CAMKII or MAPK mediate setting of the synaptic tags 
in LTP/-LTD respectively.  
Fig. 12A shows synaptic tagging in LTP in presence of the CaMKII inhibitor, KN-
62. Induction of late-LTP in synaptic input S1, fifteen minutes after induction of late-LTP 
in S1, 5 µM KN-62 was applied and 45 min later ( i.e., 30 min after drug application) an 
early-LTP was induced in the second synaptic input S2. KN-62 was washed out 1 h after 
its application. As it is seen in the Fig. 12A, the maintenance of late-LTP was unaffected 
(filled circles) in S1 while the conversion of early into late-LTP in S2 (Fig. 12A; open 
circles) through processes of synaptic tagging was prevented by the CaMKII inhibitor 
revealing that setting of the ‘tag’ or ‘tag complex' in LTP tagging is a CaMKII-dependent 
process. The potentials in S2 reached near baseline levels immediately resembling a 
short-term potentiation (STP) and then slowly resume or resemble an early-LTP. Unlike 
early-LTP, STP does not set a tag (Frey and Morris, 1997), therefore CaMKII inhibitor 
resets the tag, but not the plasticity-related proteins. 
 The next main questions were: Are LTP-tags and LTD-tags similar or not? Does 
CaMKII also mediate the setting of synaptic ‘tags’ in LTD? Keeping these questions in 
mind we investigated the role of CaMKII during LTD tagging.  As it is shown in Fig. 12B 
late-LTD was induced in S1 (filled circles), 45 min thereafter, early-LTD in S2 was 
induced but now under the influence of KN-62 (drug applied 30 min before and 30 min 
after the induction of early-LTD in S2). Here the tagging interactions were not influenced 
by the CaMKII inhibitor, i.e., the conversion of early- to late-LTD was intact. These 
results revealed that the setting of the LTD-tags is a CaMKII- independent process and 
thus, the tags for LTP and LTD seem to be different.  
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If CaMKII mediates the setting of synaptic tags in LTP, but not for LTD, then 
which molecule can mediate the specificity of the tag for LTD? We next investigated the 
role of MAPK. In a first series of experiments we investigated its role for LTP tagging. 
Fig. 12C represents a similar experiment as Fig. 12A, but with the exception that instead 
of the CaMKII-inhibitor KN-62, 20 µM of the MAPK inhibitor U0126 was used. Here the 
early -LTP in S2 (Fig. 12C open circles) was transformed into late-LTP showing the 
tagging interactions between late-LTP in S1 (filled circles) and early-LTP in S2. This set 
of experiments revealed that the setting of the LTP-tag is independent of MAPK-activity. 
Fig. 12D shows the role of U0126 on LTD-tagging. The same experiment as in Fig. 12B, 
but instead of KN-62 MAPK inhibitor, U0126 was applied. Here the transformation of 
early- into late-LTD is prevented, showing that the setting of the LTD-tag is a MAPK-
dependent process.  
The persistence of LTP or LTD is dependent on the setting of the tag during early-
LTP/-LTD and the availability of PRPs.  Earlier experiments from our laboratory have 
shown that late-LTP can be induced also during protein synthesis inhibition if a synaptic 
tag is set and PRPs are available, e.g. provided the induction of a late plasticity form in 
another synaptic input within a distinct time window (Frey and Morris, 1997). We have 
shown that CaMKII and MAPK inhibitors prevent late-LTP and LTD (see Fig. 11A, D, E, 
and G) and that CaMKII and MAPK mediates the setting of tags in LTP and LTD 
respectively. Therefore, we further studied their role during the subsequent induction of 
late-LTP in both S1 and S2, whereas the CaMKII inhibitor was applied during the 
induction of late-LTP in S2. Fig.12E shows that induction of late-LTP in S1 (filled circles) 
and S2 (open circles), but S2 in the presence of KN-62. Here induction of late-LTP in S2 
in presence of KN-62 prevents the setting of the tag and thus prevent the expression of 
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late-LTP in S2. This experiment again confirms the results obtained in Fig. 12A, that 
setting of LTP tag is mediated by the CaMKII.  Fig. 12B showed that the setting of the 
LTD-tag is a CaMKII-independent process. We verified the validity of this experiment by 
inducing late-LTD in S1 (Fig. 12F, filled circles) in the absence of KN-62, fifteen minutes 
after the induction of late-LTD in S1 the KN-62 was applied and 45 minutes after late-
LTD in S1, late-LTD in S2 was induced (open circles). Here the persistence of late-LTD 
in S2 was intact, supporting the fact that CaMKII inhibition did not affect the setting of 
the LTD-tags in S2. 
Fig. 12C represents that MAPK do not mediate the setting of tags in LTP. Thus, 
we next investigated the role of MAPK during LTP-tagging similar to the experiments 
described above for CaMKII (Fig 12E and F). Thus, instead of KN-62 the MAPK inhibitor 
U0126 was used. Interestingly, the persistence of late-LTP in S2 (Fig. 12G open circles) 
was not prevented indicating that MAPK are not involved in LTP-tagging, whereas they 
mediate setting of tags in LTD (Fig. 12H). 
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Fig. 12. Role of CaMKII and MAPK on synaptic tagging in LTP and LTD. 
(A)  Induction of late-LTP in S1 (filled circles) followed by early-LTP in S2 (open circles) 45 min after 
tetanization of S1.  Early-LTP in S2 was induced in the presence of the CaMKII inhibitor KN-62 (open 
rectangle, 5 µM, drug applied 30 min before and 30 min after the induction early-LTP in S2, n=8).  (B) 
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Late-LTD was induced in S1 without drug application (filled circles). Fifteen minutes after  late-LTD 
induction  in S1, KN-62 (5 µM) (open rectangle) was added and elapsed for the next 1 h  and 45 min after 
late- LTD of S1 early-LTD was induced in input S2, but now under the presence of KN-62 (open circles) 
(n=7). (C) The same experiment as in (A) with the exception that the induction of early-LTP in S2 (open 
circles) was in the presence of the MAPK inhibitor U0126 (n=7). (D) The same experiment as in B with the 
exception that the induction of early-LTD in S2 (open circles) was in the presence of the MAPK inhibitor 
U0126 (n=7). (E) Late-LTP was induced in S1 without drug application (filled circles). Fifteen minutes after 
SLFS in S1, KN-62 was added and 45 min after LTP of S1, late-LTP was induced in S2 but now under the 
influence of KN-62 (open circles). Under these conditions late-LTP in S2 was prevented (n=6). (F) Late-
LTD was induced in S1 without drug application (filled circles). Fifteen minutes after SLFS in S1, KN-62 
was added and 45 min after LTD of S1, late-LTD in S2 was induced but now under the influence of KN-62 
(open circles). Under these conditions late-LTD on S2 was still observed (n=6). (G) The same experiment 
as in E with the exception that the induction of late-LTP in S2 (open circles) was in presence of the MAPK 
inhibitor U0126. Under these conditions late-LTP in S2 was still observed (n=6). (H) The same experiment 
as in F with the exception that the induction of late-LTD in S2 (open circles) was in the presence of the 
MAPK inhibitor U0126. Under these conditions late-LTD in S2 was prevented (n=6).  
 Triplets of filled arrows indicate the time point of STET for inducing late-LTP and hatched arrow 
represents SLFS of the corresponding synaptic input for inducing late-LTD. Analog traces represent 
typical Field EPSPs 30 min before (dotted line), 30 min (dotted line) and 8 h (closed line) after STET or 
SLFS. 
 
3.9. Role of CaMKII and MAPK during synaptic cross tagging.  
We investigated the role of CaMKII or MAPK inhibition on processes of cross-
tagging. Fig. 13A represents data where late-LTD was induced in S1 (filled circles).  
Fifteen minutes later, KN-62 was applied for the next 1h. Then, 45 minutes after the 
induction of late-LTD in S1, early-LTP was induced in S2 (open circles) in the presence 
of KN-62. In this case, early-LTP was not transformed into late-LTP by processes of 
cross-tagging, confirming the findings described Fig. 12A and E. CaMKII mediates the 
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setting of LTP-specific tags and if blocked, cross-tagging can not occur. Fig. 13B 
represents a similar experiment as Fig. 13A but by using a different CaMKII inhibitor, AIP 
at a concentration of 5 µM, which revealed the same results. 
Next, we changed the order of the induction of LTP and LTD. Fig. 13C and D 
allowed us to confirm that CaMKII does not mediate the setting of tag in LTD. Induction 
of late-LTP in S1 (filled circles) followed by early-LTD in S2 (open circles) but the latter in 
the presence of KN-62 did not prevent cross-tagging. Early-LTD was transformed into 
late-LTD. Results shown in Fig. 13D confirm these experiments using a second 
structurally different inhibitor, AIP.  
Fig. 13E-H represents the role of MAPK on cross-tagging by using the same 
experimental designs. In Fig. 13E and F are similar to Fig. 13C and D but now with the 
use of the MAPK inhibitors U0126 or PD98059. Here the conversion of early-LTD into a 
late-LTD in S2 is prevented by both MAPK inhibitors (open circles).  In an opposite 
series of experiments, i.e, an experimental design similar to that in Fig. 13A and B the 
role of MAPK for cross-tagging was investigated. As it is shown in Fig. 13G and H, 
U0126 or PD98059 did not prevent the setting of the tag in S2 , thus it could utilize the 
proteins synthesized from the late-LTD synaptic input S1 (filled circles) resulting in the 
transformation of a transient early-LTP into a late-LTP lasting 8 h (open circles). 
 76
                      
A B
C D
FE
G H
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
n=6
SLFS
  S1
WTET
   S2
KN-62
Time  (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
n=6
AIP
SLFS
  S1
WTET
   S2
Time  (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
n=6KN-62
STET
   S1
WLFS
   S2
Time (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
200
AIP
n=5
STET
  S1
WLFS
   S2
Time  (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
n=7U0126
STET
  S1
WLFS
   S2
Time (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
200
n=3PD098059
STET
  S1
WLFS
   S2
Time (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
200
n=7
U0126
SLFS
  S1
WTET
   S2
Time (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
S1 S2
-60 0 60 120 180 240 300 360 420 480 540
0
25
50
75
100
125
150
175
200
n=4
PD098059
SLFS
  S1
WTET
   S2
Time (min)
Fi
el
d 
EP
SP
(m
Vm
s-
)%
3 mV
3 ms
 
       
Fig. 13. Role of CaMKII and MAPK on ‘cross-tagging’ 
(A) Late-LTD was induced in S1 without drug application (filled circles). Fifteen minutes after SLFS in S1, 
KN-62 was added and 45 min after late-LTD of S1, early-LTP in S2 was induced but now under the 
influence of KN-62 (open circles; (n=6)). (B) The same experiment as in (A) with the exception that the 
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induction of early-LTP in S2 (open circles) was in presence of second structurally different CaMKII inhibitor 
AIP (5 µM; n=6). (C) Induction of late-LTP in S1 (filled circles) was followed by early-LTD in S2. Here, 
early-LTD was transformed into late-LTD indicating cross-tagging between late-LTP and early-LTD 
irrespective of the inhibition of CaMKII by KN-62 (open circles) (n=6). (D) The same experiment as in (C) 
with the exception that the induction of early-LTD in S2 (open circles) was in the presence of another 
CaMKII inhibitor AIP (n=5). (E) Induction of late-LTP in S1 (filled circles) was followed by early-LTD in S2, 
but the latter in the presence of the MAPK inhibitor U0126. Here, early-LTD was not transformed into late-
LTD (open circles; n=7). (F) The same experiment as in E with the exception that the induction of early-
LTD in S2 (open circles) was in presence of another MAPK inhibitor PD98059 (n=3). (G) Late-LTD was 
induced in S1 without drug application (filled circles). Fifteen minutes after SLFS in S1, U0126 was added 
and 45 min after late-LTD of S1, early-LTP in S2 was induced but now under the influence of U0126 (open 
circles). Under these conditions early-LTP on S2 was transformed into late-LTP (n=7). (H) The same 
experiment as in (G) with the exception that the induction of early-LTP in S2 (open circles) was in 
presence of the MAPK inhibitor PD098059 (n=4). 
Triplets of filled arrows indicate the time point of STET for inducing late-LTP and hatched arrow 
represents SLFS of the corresponding synaptic input for inducing late-LTD. Analog traces represent 
typical Field EPSPs 30 min before (dotted line), 30 min (dotted line) and 8 h (closed line) after STET or 
SLFS. 
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4. Discussion 
 
4.1. RLTP and synaptic tagging 
My initial studies were concentrated on the effects of rolipram, a 
phosphodiesterase (PDE) inhibitor, on long-term potentiation (LTP) and synaptic 
tagging. These studies were based on the findings that rolipram ameliorates 
impairments of learning and memory in rats and mice, and suggest that rolipram might 
act by elevating cAMP levels (Imanishi et al., 1997). Ahmed and Frey (Ahmed et al., 
2004;Ahmed and Frey, 2003;Ahmed and Frey, 2005b;Ahmed and Frey, 2005a)  
identified a type IV-specific phosphodiesterase gene, PDE4B3, the first cAMP-specific 
phosphodiesterase to be associated with LTP and is specifically regulated during 
hippocampal CA1 LTP. Barad et al. have demonstrated that in mice low doses of 
rolipram can act to potentiate and extend LTP at the CA3-CA1 synapse in response to a 
stimulus that normally induces LTP lasting less than 1.5 h and improves memory (Barad 
et al., 1998). Targeting the degradative enzyme, PDE, may be particularly useful 
because partial inhibition of degradation may be undetectable at basal levels of 
substrate, when the degradative enzyme is likely to be present in great excess, and 
some mechanisms may compensate for low levels of inhibition (Dessauer et al., 1996). 
Because rolipram is a competitive inhibitor with cAMP for PDE, our results are most 
consistent with a model in which basal adenylyl cyclase activity is reduced to match that 
of the inhibited PDE through phosphorylation by PKA. 
The notion that PDE4B3 is specifically regulated during different phase of LTP let 
us speculate that PDEs could act as PRPs or can regulate the synthesis of PRPs (see 
(Frey and Morris, 1998a;Sajikumar and Frey, 2004a)) whose synthesis is induced by the 
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induction of long-lasting plastic events. A PDE would represent an ideal general PRP 
since its direct effect on specifically regulating PKA-activity could drive a synapse either 
to increase or decrease its efficacy, thus expressing LTP or LTD, respectively 
(Sajikumar and Frey, 2004a). 
We found that the type IV-specific PDE inhibitor rolipram can prolong an early 
form of LTP- which normally decays within 3-4 h - to a long-lasting form of LTP with 
duration of at least 6 h, the latest time point we have investigated (Fig. 6B and C). These 
results obtained in hippocampal slices from rats confirm the findings in mice published 
by Barad et al., 1998. We could also find that application of rolipram after the induction 
of LTP had no effect (Fig. 6D). Therefore the action of rolipram is synapse- and activity-
specific. We used a concentration of rolipram which will not effect the basal cAMP 
concentration because toxicity appeared at a dose that raised basal cAMP levels as 
reported by Barad et al (Barad et al., 1998). 
 In addition to these data, we now describe that this reinforcement of early-LTP by 
rolipram is dependent on the activation of the NMDA-receptor and on protein synthesis 
(Fig. 6E and F). Stimulation of N-methyl-D-aspartate (NMDA) receptors on neurons 
activates both cAMP and cGMP signaling pathways. These results are strengthened by 
the fact that the PDE4 inhibitor, rolipram enhanced the ability of NMDA to increase 
cAMP in the neurons and PDE inhibitor-augmented effects of NMDA on cAMP and 
cGMP formation were antagonized by 5-methyl-10,11-dihydro-5H-dibenzo[a,d] 
cyclohepten-5,10-imine maleate (MK-801), verifying NMDA receptor mediation (Suvarna 
and O'Donnell, 2002).  
Furthermore, the induction of late-LTP requires the activation of protein kinase A 
(PKA) through cAMP -dependent processes (Frey et al., 1993). The substrate of the 
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type IV-PDE is cAMP. Thus, rolipram, as a PDE inhibitor, may enhance the translational 
machinery by increasing cAMP-levels and PKA-activity. These findings suggested that 
amplification of signals through the cAMP pathway might lower the threshold for 
generating long-lasting long-term potentiation. Monti et. al showed recently that rolipram 
delivery increased the basal rat hippocampal expression and phosphorylation of CREB, 
as well as the expression of the cAMP-dependent, memory-related protein, Arc (Monti et 
al., 2005). Furthermore, the increase of CREB phosphorylation and Arc expression 
consequent to the learning experience was enhanced in rolipram-treated rats, compared 
to controls. In addition, PDE-related processes which could counteract with potentiation-
related intracellular processes would be depressed. Thus, early-LTP- a normally 
transient form of LTP, which is characterised by the setting of protein-synthesis-
independent tags (Frey and Morris, 1997;Frey and Morris, 1998a) can be transformed 
into a protein synthesis-dependent late-LTP. 
 It was speculated that rolipram, by generally raising cAMP concentration 
throughout the brain, may enhance memory by a different mechanism perhaps by 
consolidating changes at recently stimulated synapses "tagged" by endogenous 
signalling mechanisms. Frey et al have demonstrated that blockade of either D2 or D1 
receptor decreases the magnitude of late phases of LTP, 2 h or more after the induction 
(Frey et al., 1991b;Frey et al., 1990). This late phase seems to involve the effects of 
cAMP on protein synthesis (Frey et al., 1993). D1/D5-receptor agonists that are 
positively coupled to adenylyl cyclase specifically induce a slowly developing long-
lasting potentiation of the field excitatory postsynaptic potential in the CA1 region of the 
hippocampus that lasts for > 6 h, an effect that is blocked by inhibitors of protein 
synthesis and NMDA-receptor (Huang and Kandel, 1995). This potentiation is also 
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blocked by the specific D1/D5-receptor antagonist SCH23390 and is occluded by the 
potentiation induced by cAMP agonists. Earlier works by Otmakhova and Lisman 
indicates that dopamine receptor agonists (such as Bromo-APB) or  antagonists (such 
as SCH23390) may enhance or limit, respectively, the extent of early-LTP after a tetanus 
of intermediate intensity (40 pulses at 100 Hz) (Otmakhova and Lisman, 1996). 
D1/D5-receptors seem to be implicated more strongly in the mechanisms of 
reinforcement (Otmakhova and Lisman, 1996) and they increase cAMP (Kebabian and 
Calne, 1979) which is important for early-LTP (Blitzer et al., 1995). Immunohistochemical 
localisation of dopamine D1/D5-receptors shows that there is heavy staining along 
pyramidal cells of the CA1 (O'Carroll and Morris, 2004). It was therefore of interest to 
study the effect of dopamine on RLTP, a rapidly developing, activity-dependent, 
synapse-specific modification.  
 The normal role of this dopaminergic activation might be to activate second-
messenger systems, such as the PKA/cAMP cascade or the ERK/MAPK pathway, and 
thereby regulate downstream gene transcription or translation (Rosenblum et al., 
2002;Frey et al., 1993). The multiple tetanic trains produce a transient rise in cAMP 
(Chetkovich et al., 1991) and a consequent activation of PKA (Blitzer et al., 1995) are 
consistent with such a possibility.  
Our studies on RLTP show that the action of rolipram was downstream of the 
D1/D5-receptor. Our earlier hypothesis suggested that a synergistic action of 
glutamatergic and dopaminergic processes specifically regulate the synthesis of 
candidate PRPs, such as of the PDE4B3 (Sajikumar and Frey, 2004a). This hypothesis 
is now strongly supported by our here presented experiments: Weak tetanization of a 
synaptic input S1 which would normally result only in early-LTP was transformed into 
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late-LTP if a subsequent RLTP was induced in input S2 (Fig. 7B). The explanation of 
that transformation could be as follows: early-LTP was induced in synaptic input S1, 
sufficient to activate a 'synaptic tag' in this input. However, the tag as such is unable to 
convert early-LTP into late-LTP (Frey and Morris, 1997). But when a subsequent weak 
tetanization was delivered to a synaptic input S2 in the presence of rolipram both inputs 
now expressed late-LTP. Each of the tetanization of S1 and S2 activated their synapse-
specific tags, but only the weak tetanization of S2 under the influence of rolipram (i.e. 
PDE inhibition), resulted in the activation of synapse-non-specific synthesis of PRPs 
which now could be captured by the 'synaptic tags' in S1 and S2, thus being able to 
express late-LTP in the two inputs. Application of rolipram after the induction of early-
LTP and without subsequent tetanization of a second synaptic input was unable to 
cause the same effect (Fig. 6D). Early-LTP induction must be co-applied with PDE-
repression to result in RLTP. Thus, induction of early-LTP does, not only lead to the 
setting of a 'tag' but is also involved in initiating synergistic events - together with PDE-
inhibition - which finally results in the synthesis of PRPs required for the expression of 
late-LTP. However, we cannot exclude that enzymes other than PDEs are also involved 
in regulating the synthesis of PRPs. Tagging of proteins in S1 whose synthesis was 
initiated by the RLTP-dependent processes in input S2; 40 min after weak tetanization of 
S1 supports our assumption that PDE may represent one PRP or may regulate the 
synthesis of PRPs. Fig. 7C and D shows that synaptic tagging by rolipram is prevented 
by protein synthesis inhibitors. 
Our results that rolipram reinforces early-LTP by increasing the cAMP 
concentration is further strengthened by the findings that rolipram, is able to restore the 
cAMP/PKA/ pathway activity and LTP (Vitolo et al., 2002;Gong et al., 2004). Rolipram 
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has been shown to reverse memory deficits produced by pharmacological blockade, 
such as N-methyl-D-aspartate (NMDA) (Zhang et al., 2000) or muscarinic blockade 
(Imanishi et al., 1997;Zhang and O'Donnell, 2000), and those induced by MAPK 
inhibitors (Zhang et al., 2004). Agents such as caffeine that have nonspecific 
phosphodiesterase inhibitory activity as well as other activities can also improve 
cognition in specific conditions (Nicholson, 1990). There is evidence that PKA activation 
in the hippocampus improves memory,(Ramos et al., 2003). Inhibition of cyclic AMP 
(cAMP)-specific PDE4 enhances memory in rodents further adds to the pharmacological 
value of the study (Zhang et al., 2005). MEM1018 and MEM1091 are newly developed 
PDE4 inhibitors that had not been evaluated as yet for their effects on working and 
reference memory but Zhang et al showed that MEM1018 and MEM1091 enhance 
memory in a manner generally similar to rolipram (Zhang et al., 2005).  
 
4.2. RLTD and Synaptic tagging 
 We investigated the role of rolipram during LTD and synaptic tagging. The type 
IV-specific PDE inhibitor rolipram can reinforce a normally transient early-LTD into a 
long-lasting form of LTD with duration of at least 6 h which we named RLTD (Fig. 8C). 
Thus, rolipram - in addition to the reinforcment of a transient early-LTP into late-LTP in 
mice or in rat hippocampal slices in vitro (Barad et al., 1998;Navakkode et al., 2004) - 
also revealed similar effects for LTD (Fig. 8C). The synapse specificity of rolipram on 
activated synapses was confirmed by the findings that application of rolipram after the 
induction of LTD had no effect on its maintenance (Fig. 8D). We also showed that this 
reinforcement of early-LTD by rolipram was dependent on the activation of NMDARs and 
protein synthesis (Fig. 8E-G).  
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Hippocampal LTD, similar to persistent hippocampal LTP, appears to require 
protein synthesis from local mRNA and for its prolonged maintenance probably also de 
novo mRNA-synthesis (Frey and Morris, 1998a;Kauderer and Kandel, 2000;Sajikumar 
and Frey, 2003;Sajikumar and Frey, 2004a;Kelleher, III et al., 2004b;Kelleher, III et al., 
2004a). Therefore, a mechanism must exist which transduces the local translational 
process to a transcriptional one. The MAPK/ERK-cascade is thought to participate in 
such a signal transduction process during LTP (Giovannini et al., 2001;English and 
Sweatt, 1997). It remained to be investigated till then, if the MAPK/ERK-cascade may 
fulfil similar function during LTD. 
 
4.3. RLTD and the role of MAPK/ERK cascade  
We could show that RLTD was prevented by inhibitors of MAPK, U0126 and 
PD98059 (Fig.10E and F). Therefore for the first time we reported that the MAPK/ERK 
cascade is involved in maintaining LTD in rat hippocampal slices in vitro. The 
cAMP/PKA-mediated activation of the ERK cascade may be an important pathway in 
regulating local protein synthesis, as well as gene expression during functional plasticity 
and memory formation. However, the specific pathways by which cAMP/PKA are 
coupled to extracellular signal regulated kinases are not yet fully understood. In a recent 
report, Morozov et al  discussed distinct pools of p42/44MAPKs during different forms of 
LTP with their specific signalling pathways (Morozov et al., 2003). One pathway for 
LTP-maintenance involves the binding of the Raf family proteins (Raf-1, A-Raf and B-
Raf) by activated Ras (Marshall, 1995). The major function of Ras in activating Raf is to 
relocate Raf to the cell membrane, where it is activated by a yet unknown mechanism 
and then in turn activates MEKs. Using mice genetically engineered to express the 
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neurofibromatosis mental retardation syndrome, Costa and co-workers provided 
evidence that a Ras/ERK hyperactivation contributes to hippocampus-dependent 
learning and related memory deficits as well as to a disruption of CA1-LTP (Costa et al., 
2002). There is also growing evidence that the NMDAR/PKC-dependent Ras/Raf-1 
pathway of MAPK/ERK-activation is one of the most important pathways for maintaining 
hippocampal CA1-LTP (English and Sweatt, 1997). However, it remains unclear which 
pathway of MAPK/ERK-activation is used for the prolonged, protein synthesis-
dependent late-LTD in CA1. In the dentate gyrus, the Ras-pathway seems also to be 
important for LTD (Murray and O'Connor, 2004). 
Here, we could show that RLTD, i.e. a prolonged LTD which seems to resemble 
the late phase of LTD, can be prevented by LT-82, an inhibitor of Rap1/B-Raf-pathway 
of MAPK activation triggered by dopaminergic D1/D5-receptor activation (Fig. 10H, and 
Fig. 14). Interestingly, manumycin-A, an inhibitor of the Ras/Raf-1-mediated MAKP 
pathway did not prevent RLTD (Fig. 10G and Fig. 14) indicating that MAPK activation is 
not mediated via Ras but Rap1 signalling. These results suggest that MAPK/ERK-
regulated processes during LTD in adult animals are mediated by D1/D5-receptor-
mediated cAMP/PKA-dependent processes.  
Rap1 exerts a dual regulation of p42/p44 MAPK by either inhibiting Raf1 or 
activating B-Raf. In addition, Rap1 can also antagonise Ras (Altschuler and Ribeiro-
Neto, 1998). Because Ras is anchored to the plasma membrane, whereas Rap is 
anchored to the membrane of endosomal compartments (Kim et al., 1990;Pizon et al., 
1994;Resh, 1996), Rap1 and Ras may regulate distinct and different pools of MAPK 
(see above) resulting in different functions.  
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Fig. 14. Schematic illustration of the possible action of rolipram during LTD, i.e. during the 
transformation of early-LTD into late-LTD in hippocampal CA1 from adult rats(adapted from Sweatt, 
2001). 
Inducion of electrically induced early-LTD by field electrodes in hippocampal CA1 neurons from adult rats 
activates glutamatergic NMDAR as well as dopaminergic D1/D5-receptors. For RLTD we could exclude 
the NMDAR-PKC/Ras mediated activation of MAKP/ERK. The interaction of NMDAR-mediated 
Ca2+/calmodulin-initiated processes with dopaminergically induced processes remain speculative but 
favour a role in marking/tagging the synapse for LTD. D1/D5-receptor-dependent processes mediate a 
cAMP/PKA-dependent, Rap1/B-Raf-mediated activation of MAPK/ERK resulting in protein synthesis and 
the transformation of early-LTD into late-LTD.  
 
If RLTD represents conventional late-LTD, it should also be characterized by 
processes of synaptic tagging. If so, then for a protein synthesis-dependent stage, 
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synapse-specific tags must be set in the activated synapse population that then can 
capture PRPs whose synthesis took place non-specifically in response to the activated 
synapses. We have shown that the induction of early-LTD in one synaptic input S1 can 
be input-specifically reinforced by rolipram to a late-LTD, which is dependent on D1/D5-
receptor activation as well as protein synthesis (Figs. 9 A-D), supporting synaptic 
tagging during RLTD.  
Although, we provide evidence that the D1/D5-cAMP/PKA-Rap1/B-Raf mediated 
pathway of MAPK/ERK-activation seems to be one of the effective pathways during 
RLTD, there remain still many open questions. For instance, although rolipram seems 
specifically to induce late-LTD we cannot fully exclude that other, additional mechanisms 
may take place during conventional, electrically-induced LTD, other than that described 
here for RLTD. The requirement of a coactivation of NMDAR and D1/D5-receptors for 
RLTD also remains unclear. We suggest that through NMDAR-interactions the 
stimulated input was tagged to interact in an input-specific manner with the PRPs, 
allowing the synapse population to express synapse-specific late-LTD.  
In addition, our results contribute to how the synthesis of PRPs, i.e., the pre-
requisite for a cellular long-lasting memory trace, might be regulated via the activation of 
modulatory, non-glutamatergic inputs, if this activation occurs within a distinct time 
window around the induction of normally transient plastic phenomena such as early-LTP 
or early-LTD at a glutamatergic input (Frey and Morris, 1998a;Frey et al., 
2001;Sajikumar and Frey, 2004a;Korz and Frey, 2003;Navakkode et al., 2004).  
We had suggested that the synthesis of both process-specific and process-non-
specific PRPs occurs during the induction of either late-LTP or late-LTD (Sajikumar and 
Frey, 2004a;Kelleher, III et al., 2004b;Sajikumar et al., 2005b). Recently, we identified 
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PKMζ as the first LTP-specific PRP (Sajikumar et al., 2005b). Furthermore, we have 
suggested that PDE4B3 could represent a process-non-specific PRP which regulates 
the synthesis of secondary PRPs maintaining either LTP or LTD (Ahmed and Frey, 
2005b;Ahmed and Frey, 2005a;Navakkode et al., 2004;Sajikumar and Frey, 
2004a;Sajikumar et al., 2005b). In addition, such regulatory PRPs might be involved in 
gene expression resulting in a local pool of mRNA whose products are specific for either 
LTP or LTD and which guarantee a prolonged maintenance of LTP or LTD beyond 8 h 
(Kelleher, III et al., 2004a;Kelleher, III et al., 2004b). Our data here provide more 
evidence for a specific role of PDEs in the regulation of processes required for the 
prolonged maintenance of hippocampal CA1-LTD.  
Our results support further the requirement of heterosynaptic activation of 
processes which are critical for the expression of a long-lasting memory trace. These 
results were confirmed by a number of other laboratories (Chen et al., 1995;Huang and 
Kandel, 1995;O'Carroll and Morris, 2004), which let us hope that the focus of research in 
synaptic plasticity will in addition to glutamatergic mechanisms also include the 
description of modulatory processes, required for the consolidation of a memory trace at 
the cellular and networks level in the adult brain. 
 
4.4. Synaptic tagging and cross-tagging: Revealing the nature of synaptic tags 
specific for LTP or LTD 
One of the major question in studying processes of synaptic tagging is: What is 
the nature of the synaptic tag? Two protein kinase families highly expressed in brain that 
have been implicated in molecular mechanisms regulating LTP are the Ca2+/calmodulin-
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dependent kinase II (CaMKII) and ERK1/ERK2 (extracellular signal-regulated kinases) 
(Soderling et al., 2001;Sweatt, 2004;Schmitt et al., 2005).  
 CaMKII is required for LTP induction and can, by itself, induce the downstream 
processes that potentiate transmission which led us to select CaMKII as a potential 
candidate for tag. More recently Hudmon et al showed that CaMKII holoenzymes were 
shown to be capable of associating with one another (or self-associate) in response to 
Ca2+ stimulation. Therefore CaMKII may form a scaffold that, in combination with other 
synaptic proteins, recruits and localizes additional proteins to the postsynaptic density. 
They also discussed the potential function of CaMKII self-association as a ´tag´ of 
synaptic activity (Hudmon et al., 2005). According to them the unique multimeric 
structure of the enzyme would thus provide a geometrically constrained scaffold onto 
which other synaptic proteins could be assembled, making CaMKII self-association an 
ideal synaptic tagging mechanism. 
 The ERK-MAPK signaling pathway is a highly conserved kinase cascade linking 
transmembrane receptors to downstream effector mechanisms (Chang and Karin, 
2001). Previous studies have demonstrated the general involvement of the ERK 
signaling pathway in synaptic plasticity, learning and memory (English and Sweatt, 
1997;Impey et al., 1998). The impact of MAPK cascade in synaptic plasticity led us to 
choose it as another possible tag candidate. 
  Our initial studies at least partially confirmed the results obtained from others 
that CaMKII or MAPK inhibition interfere with the induction of LTP and LTD (Mayford et 
al., 1995;Stevens et al., 1994;Schnabel et al., 1999;English and Sweatt, 1997;Kelleher, 
III et al., 2004a) (Fig. 11 A,C,E and G ). Extracellular bath application of the selective 
CaMKII inhibitor KN-62 to hippocampal slices in vitro blocked the induction of LTD and 
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of induction of LTP (Stanton and Gage, 1996;Bortolotto and Collingridge, 1998). 
Moreover, the concentration of MAPK inhibitor, U0126 which we used (Fig. 11 E), 
blocked the late phase of LTP leaving the early phase intact (Sweatt, 2004;Thomas and 
Huganir, 2004), which also supports the findings in Aplysia that ERK activation is 
necessary for long-term facilitation (LTF) but not for the short term facilitation (STF) 
(Martin et al., 1997). CaMKII or MAPK inhibition after the induction of LTP or LTD had no 
effect on its maintenance (Fig. 11B,D,F and H) which supports the findings reported 
earlier that inhibition of ERK activation after the induction of LTP does not reverse LTP 
in either area CA1 or the  dentate gyrus (Coogan et al., 1999;English and Sweatt, 
1997;Kelleher, III et al., 2004a;Impey et al., 1998;Kanterewicz et al., 2000). 
Here we report for the first time that p42/44 MAPK activation is essential for LTD 
in CA1 region of the hippocampus in vitro (Fig. 11G). Different stimulation protocols may 
activate different ERK signal cascade (Thiels and Klann, 2001), as in strong low 
frequency stimulation which we used in our studies seemed to activate p42/44MAPK. 
One hypothesis to consider is that ERK is a general regulator of neuronal protein 
synthesis in response to different extracellular stimuli, and the specificity of the response 
(LTP or LTD) may be determined by the pattern of synaptic activity. Alternatively, the 
activation of ERK may be differentially regulated by NMDARs and mGluRs via different 
small GTPases. Recent work suggests that Rap1 regulates a specific subcellular fraction 
of ERK activity in hippocampal neurons (Morozov et al., 2003).  
It was proposed earlier that spine morphological changes may contribute to the 
setting of tags in LTP (Frey and Morris, 1998a). We extend our hypothesis that the 
enhanced spine density in the activated synapses can hold the CaMKII in the post 
synaptic density thus enhancing the AMPARs conductance, because  CaMKII drives the 
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insertion of new AMPA receptors into synapses (Wu et al., 1996;Lisman and 
Zhabotinsky, 2001).  We have recently reported that an atypical PKC isotype, PKMζ acts 
as an LTP-specific PRP (Sajikumar et al., 2005b). There are considerable evidence that 
PKMζ increases the AMPA receptor responses (Ling et al., 2002;Osten et al., 1996), 
thus we propose that the activated synapses holding the CaMKII enhances the AMPAR 
responses to a further level so that the tagging of PKMzeta from a strongly tetanized 
input to weekly tetanized inputs  occurs in LTP tagging. 
Depotentiation can reset the tag if it is applied within 5 min after the induction of 
early-LTP (Sajikumar and Frey, 2004b). Our present results are consistent with these 
findings that CaMKII inhibition results a depotentiation like effects in early LTP thus may 
contribute the resetting of synaptic tags in LTP (Fif. 12A). Induction of late-LTP in S1 
followed by weak tetanus to induce early-LTP in presence of CaMKII inhibitor KN-62 
prevents LTP tagging. Therefore tagging of proteins from a strongly tetanised input to 
weakly tetanised input requires the mediation of CaMKII. We have shown earlier that 
short term potentiation or STP is incapable of generating a synaptic tag (Frey and 
Morris, 1997), therefore the depotentiating effect shows that CaMKII inhibition 
completely degrades the tag. To further confirm our results we induced late-LTP in both 
synaptic inputs S1 and S2, but S2 in presence of CaMKII inhibition. In this set of 
experiments also we could not observe a tagging interaction between the inputs S1 and 
S2. We further tested the role of CaMKII inhibition in LTD. Induction of late-LTD followed 
by early-LTD in the presence of KN-62 had no effect on LTD tagging (Fig.12 B) which 
was further confirmed by inducing  late-LTD in both synaptic inputs but S2 under the 
influence of KN62 (Fig.12 F). Thus, our results provide strong evidence for a specific role 
of CaMKII in the setting of LTP-specific tags (Fig. 12 A and E). 
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 In a recent review Thomas et al. speculated that, whether translocation of ERK 
can ’tag’ the activated synapses by phosphorylation of specific substrates (Thomas and 
Huganir, 2004). Our results allow us to point out a critical role for ERK1/ERK2 for 
mediating the setting of LTD tags (Fig. 12D and H) but not for LTP tags (Fig. 12 C and 
G). Gallagher et al. demonstrated a role for ERK in mGluR-LTD in area CA1 of the rat 
hippocampus (Gallagher et al., 2004). ERK is specifically important in mGluR- and 
protein synthesis-dependent LTD. We confirmed these findings by inducing late-LTD in 
both inputs, however having the second input under the influnece of U0126. Late-LTD in 
S2 was prevented  (Fig. 12H). The setting of LTP-tags was independent of MAPK (Fig. 
12C and G). Thus, these results support our assumtion that the setting of LTD-tags is 
mediated by MAPK (Fig. 12D and H) 
.   
4.5. Role of PKMζ, PDE4B3, CaMKII and MAPK in synaptic tagging/cross tagging 
in a CA1 pyramidal neuron  
Rolipram can prolong an early-LTP into late-LTP (RLTP) and it reinforces early-
LTD into late-LTD (RLTD) at the same concentration. Therefore, unlike PKMζ, which is 
both necessary and sufficient for LTP but not for LTD, PDE4B3 is the first known 
process-non-specific regulatory protein which regulates the synthesis of process-non-
specific PRP or is involved in the regulation of the synthesis of process-specific PRPs, 
(Navakkode et al., 2004;Ahmed et al., 2004;Ahmed and Frey, 2003). An LTD-specific 
PRP has yet to be identified.  
Moreover, we were able to show that CaMKII acts as an LTP-specific tag 
molecule, although CaMKII is also necessary for the maintenance of both LTP and LTD. 
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MAPK, on the other hand mediate the setting of LTD-specific tags, although MAPK are 
also essential for the maintenance of both LTP and LTD (Fig. 16). 
 
                     
(Adapted from Sajikumar. S, Navakkode.S, Frey JU. J Neurosci. 2005 Jun 15;25(24):5750-6.) 
Fig. 16. Role of PKMζ, PDE4B3, CaMKII and MAPK in synaptic tagging/cross tagging in a CA1 
pyramidal neuron. Hypothesis of the activity-dependent synthesis of a pool of PRPs that are either 
specific for LTP (red triangles), specific for LTD (blue trapezoids), or non-specific (mixed red and blue 
trapezoids). PDE4B3 is the first known non-specific PRP, which could be also important for process-
specific aspects such as the regulation of the synthesis of process-specific PRPs (Ahmed and Frey, 2003; 
Navakkode et al. 2004; Ahmed at al., 2004). PKMζ is the first identified LTP-specific PRP.  An LTD-
specific PRP has yet to be identified. CaMKII acts as the process-specific tag molecule in LTP. MAPK 
represents a process-specific molecule that mediates the setting of LTD tag. We suggest that not only 
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does the process-specific tag consists of a complex machinery of molecules specific for LTP (red symbol 
at the synapse) or LTD (blue symbol at the synapse in Fig. 16; Frey and Morris, 1998; Sajikumar and 
Frey, 2004), but also PRPs represent a pool of proteins expressing their effector roles by selective 
interactions with these process-specific tag complexes, in addition to basic short-term plasticity functions. 
D1-dopaminergic D1/D5-receptor; Glu- glutamatergic synapse. 
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5. Conclusions 
The principal findings of this dissertation are 
1) Rolipram, a selective cAMP phosphodiesterase inhibitor, reinforces an early form 
of LTP, which lasts less than 2-3 h into a long-lasting LTP (RLTP) which is stable 
up to a recorded time period of 6 h in hippocampal CA1 region in vitro. 
2) RLTP is protein synthesis- and NMDA-receptor- dependent, similar to 
conventional late-LTP. 
3) RLTP can interact with processes of synaptic tagging. 
4) The action of rolipram is downstream of D1/D5-receptor activation during LTP. 
5) cAMP-dependent processes are directly involved in the synthesis of plasticity-
related proteins and PDE represents one PRP mediating LTP. 
6) Rolipram reinforces an early form of LTD which lasts for less then 2-3 h into a 
long-lasting form (RLTD) which is stable for 6 h recorded time period. Thus for 
the first time we report a reinforcement-effect in LTD. 
7) RLTD is protein synthesis- and NMDA-receptor-dependent similar to late-LTD. 
8) RLTD, similar to RLTP, can interact with processes of synaptic tagging. 
9) Synaptic tagging by RLTD is dependent on the activation of D1/D5-receptors. 
10) Mitogen-activated protein kinases (MAPK; ERK1/ERK2) mediate the 
reinforcement-effect of rolipram in LTD. 
11) Activation of MAPK by rolipram is mediated through the rap-signalling pathway 
rather than ras signalling pathway during LTD. 
12) The cAMP-dependent processes are directly involved in the synthesis of 
plasticity-related proteins (PRPs) for both LTP and LTD. 
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13) Thus for the first time we report a process-unspecific PRP, i.e. PDE that 
regulates opposing forms of plastic events like LTP and LTD. 
14) CaMKII or MAPK (ERK1/ERK2) inhibition during the induction of LTP or LTD 
prevents their maintenance. 
15) CaMKII or MAPK (ERK1/ERK2) inhibition after the induction of LTP or LTD has 
no effect on their maintenance. 
16) CaMKII mediates the setting of tags specific for LTP, but not for LTD. 
17) MAPK (ERK1/ERK2) mediates the setting of tags specific for LTD, but not for 
LTP. 
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Appendices 
 
I. Zusammenfassung 
 
Gedächtnisformierung und -konsolidierung unterliegen sehr wahrscheinlich 
langfristigen plastischen Prozessen, welche die synaptische Übertragungsrate zwischen 
Neuronen modulieren. Die bisher am besten untersuchten Modelle synaptischer 
Plastizität sind die Langzeitpotenzierung (LTP) und die Langzeitdepression (LTD). Die 
bisherige Kenntnis der zellulären und molekularen Mechanismen die der LTP und LTD 
unterliegen, wurden überwiegend an hippokampalen Schnittpräparaten in vitro 
gewonnen. 
Meine ersten Studien konzentrierten sich auf den Effekt von Rolipram, einem 
Hemmer der Typ IV-spezifischen cAMP-Phospodiesterase (PDE), auf späte Phasen 
funktioneller plastischer Prozesse in der CA1 Region hippokampaler Schnittpräparate 
der Ratte. Ich konnte zeigen, das die frühe Phase der LTP (early-LTP) die 
normalerweise innerhalb von 2 h - 3 h auf baseline-Niveau abklingt in eine späte Form 
der LTP (late-LTP) transformiert wird (> 6 h), wenn während der Tetanisierung  Rolipram 
appliziert wurde. Diese Rolipram-verstärkte LTP (RLTP) ist NMDA-Rezeptor- und 
proteinsynthese-abhängig. Da die Aktivierung der cAMP- Signalkaskade während der 
Induktion eine late-LTP Dopaminrezeptoraktivität (D1/D5) in der CA1-Region erfordert 
(Frey et al., 1989; Frey et al., 1990), überprüften wir, ob die RLTP von dopaminerger 
Aktivität abhängt. Da die RLTP ebenso wie die konventionelle späte LTP von 
Proteinsynthese abhängt, untersuchte ich, ob Rolipram Prozesse des synaptic tagging 
beeinflußt. Hemmung der PDE und nachfolgende Induktion einer RLTP in einer 
Population von Synapsen (S1) erlaubte die Transformation einer early-LTP in eine late-
LTP in einer zweiten, von der ersten unabhängigen Synapsenpopulation (S2) derselben 
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Neuronenpopulation. Dieses Ergebnis unterstützt unsere Hypothese, daß cAMP-
abhängige Prozesse unmittelbar in die Synthese plastizitätsrelevanter Proteine (PRPs) 
involviert sind. 
In neueren Studien wurden Interaktionen zwischen LTP  und LTD über synaptic tags 
nachgewiesen (Sajikumar & Frey, 2004a) und als „cross-tagging“ in die Literatur 
eingeführt. Da der tag der durch die Induktion der frühen Phase einer der beiden 
Formen der synaptischen Plastizität von PRPs profitieren kann, deren Synthese durch 
die Induktion der späten Phase von LTP oder LTD angestossen wurde, stellte sich die 
Frage nach der Rolle prozeß-unspezifischer und –spezifischer Proteine. Wir konnten 
PKMζ als erstes LTP-spezifisches Protein nachweisen, das sowohl nötig als auch 
hinreichend für die Aufrechterhaltung der late-LTP aber nicht der late-LTD ist (Sajikumar 
et al., 2005). Da wir zeigen konnten, daß eine PDE-Inhibierung zur Verstärkung der 
early-LTP führt, stellte sich nun die interessante Frage, ob es auch zu einer LTD-
Verstärkung führen kann (RLTD. 
In der vorliegenden Arbeit zeige ich, daß in der CA1-Region hippokampaler 
Schnittpräparate adulter Ratten die Gabe von Rolipram während des Tetanus ebenso zu 
einer Transformation einer early-LTD in eine late-LTD führt. Zudem konnte ich zeigen, 
daß diese Transformation NMDAR- und proteinsyntheseabhängig ist, sowie eine 
dopaminerge Aktivierung erfordert und somit ähnlichen Mechanismen zu unterliegen 
scheint, wie eine elektrisch induzierte late-LTD. Daher stellte sich die Frage, ob synaptic 
tagging während einer RLTD nachzuweisen ist. Ich konnte zeigen, das in S1 eine LTD-
Verstärkung zu beobachten ist, wenn in S2 eine early-LTD in Anwesenheit von Rolipram 
induziert wird. Somit wären die Kriterien von synaptic tagging für die RLTD erfüllt.  
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Während die molekularen Mechanismen verschiedener Formen der LTP relativ gut 
untersucht sind, ist dies für die LTD nicht der Fall. Wir begannen daher, die 
Mechanismen des Rolipram-Effektes auf die LTD genauer zu untersuchen. Wir konnten 
durch Einsatz von Inhibitoren (U0126 und PD98059) der mitogen-aktivierten 
Proteinkinase (MAPK) zeigen, daß die durch extrazelluläre Signale regulierte Kinase 
(ERK1/ERK2) induzierte Signalkaskade in RLTD involviert ist. Außerdem studierten wir 
die Rolle spezifischer Kaskaden durch die ERK1/ERK2 während RLTD aktiviert wird und 
fanden eine spezifische Rolle der Rap/PKA abhängigen Kaskade. Wir konnten unter 
Einsatz von spezifischen Inhibitoren des Ras/Raf-1 Signalweges (Manumycin) und des 
Rap/B-Raf Pfades (LT-82) zeigen, das die MAPK-Aktivierung während RLTD ausgelöst 
wird durch die synergistische Interaktion der der  NMDAR und D1/D5-Rezeptor 
abhängigen Rap/B-Raf Signalwege, jedoch nicht des Ras/Raf1 Pfades. 
Zusammenfassend zeigen diese Ergebnisse, daß PDE4B3 ein prozeß-unspezifisches 
Protein ist, welches die Ausbildung einer LTP und/oder LTD reguliert. 
In einem nächsten Schritt interessierte uns die grundlegende Frage: was ist der 
synaptic tag? Gibt es spezifische tags für LTP und LTD? Viele Forschergruppen haben 
spekuliert, das der tag die aktivierte, phosphorylierte Form eines Proteins sein könnte 
oder auf Änderungen des Zytoskeletts wie etwa spine-Durchmesser oder Aktin-
Filamente beruhen könnte. Wir studierten die Rolle zweier vielversprechender 
Kandidaten CaMKII und ERK1/ERK2 (MAPK) als LTP- oder LTD-spezifische tags. 
Zunächst bestätigten wir die Ergebnisse anderer Labors, daß  die Inhibierung der 
CaMKII oder MAPK nach Induktion von LTP oder LTD keine Rolle auf deren 
Aufrechterhaltung hat. Wir konnten erstmals zeigen, das p42/44 MAPK auch für die 
Aufrechterhaltung der LTD benötigt wird. 
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Ebenso konnten wir durch Einsatz eines spezifischen Hemmers (KN-62) zeigen, das 
das Setzen eines tags oder tag-Komplexes während LTP jedoch nicht LTD ein CaMKII-
vermittelter Prozeß ist. Zusätzlich zu dem klassischen tagging-Experiment, sicherten wir 
dieses Ergebnis ab, indem in beiden Inputs (S1 und S2) eine late-LTP induzierten, in S2 
allerdings in Gegenwart von KN-62. Während in S2 late-LTP geblockt wird, bleibt late-
LTP in S1 erhalten. Induktion von late-LTD in beiden Inputs in Gegenwart von KN-62 in 
S2 hatte jedoch keinen Einfluß auf  deren Aufrechterhaltung.  
Nach Klärung der Rolle von CaMKII im Setzen des tags während LTP stellte sich die 
Frage nach einer spezifischen Kinase die das Setzen eines LTD-tags vermittelt. Wir 
wiederholten die gleichen Experimente wie für CaMKII oben beschrieben mit zwei 
spezifischen MEK-Hemmern (U0126 und PD98059). Wir konnten zeigen, daß im 
Gegensatz zu CaMKII, MAPK keinen  Einfluß auf das Setzen LTP-spezifischer tags hat, 
jedoch die Aktivierung LTD-spezifischer tags vermittelt.  
Als nächstes untersuchten wir die Frage, ob mit cross-tagging die weitere Prozeß-
Spezifität der tags charakterisiert werden kann. Hierzu induzierten wir late-LTD in S1 
und nach 45 min early-LTP in S2 in der Gegenwart eines CaMKII-Hemmers (KN-62 und 
Autocatamide 2-inhibitory peptide, AIP). Es zeigte sich keine Transformation in eine late-
LTP in S2, es fand also kein cross-tagging statt. Die Durchführung des gleichen 
Experimentes in Gegenwart von MAPK-Hemmern (U0126 und PD98059) führte zudem 
zu keiner Transformation der early-LTD in eine late-LTD, was die spezifische Rolle für 
MAPK während LTD-taggings bestätigt. Zusammenfassend konnten wir zeigen, das 
LTP-tagging durch CaMKII vermittelt wird, während MAPK in LTD-tagging involviert ist. 
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